WO2004084990A1 - Heart treatment device and heart treating method - Google Patents

Heart treatment device and heart treating method Download PDF

Info

Publication number
WO2004084990A1
WO2004084990A1 PCT/JP2004/003618 JP2004003618W WO2004084990A1 WO 2004084990 A1 WO2004084990 A1 WO 2004084990A1 JP 2004003618 W JP2004003618 W JP 2004003618W WO 2004084990 A1 WO2004084990 A1 WO 2004084990A1
Authority
WO
WIPO (PCT)
Prior art keywords
heart
interval
stimulation
heartbeat
heart rate
Prior art date
Application number
PCT/JP2004/003618
Other languages
French (fr)
Japanese (ja)
Inventor
Yoshihito Fukui
Original Assignee
Terumo Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corporation filed Critical Terumo Corporation
Publication of WO2004084990A1 publication Critical patent/WO2004084990A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36114Cardiac control, e.g. by vagal stimulation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions

Definitions

  • the present invention relates to a heart treatment device and a heart treatment method for slowing down a heart rate decrease caused by vagal nerve stimulation.
  • sudden cardiac deaths especially those caused by heart disease, are called sudden cardiac deaths, the number of which is about 50,000 annually in the country.
  • the immediate cause of sudden cardiac death is the development of hemodynamically disrupted ventricular tachycardia—ventricular fibrillation, called lethal arrhythmias.
  • the ventricle In ventricular tachycardia, the ventricle pulsates abnormally prematurely, and in ventricular fibrillation, the individual muscle fibers constituting the ventricle begin to excite in a chaotic manner, and the entire ventricle trembles little by little.
  • a fatal arrhythmia occurs, the pump function of the heart is reduced or lost, and it is impossible to pump the necessary blood to the whole body, causing loss of consciousness due to a decrease in cerebral blood flow. Failure to do so may result in death.
  • ICD Implantable cardioverter defibrillators
  • ICD performs defibrillation by giving an electric shock to the heart when the occurrence of ventricular tachycardia / ventricular fibrillation is detected.
  • ICD is a so-called coping therapy device that operates after a heart abnormality has occurred, and a large electric shock for defibrillation may damage heart tissue.
  • cardiac activity is governed by the autonomic nervous system, but the autonomic nervous system has a sympathetic nervous system and a parasympathetic nervous system.
  • Increased (strained) sympathetic activity increases heart activity (heart rate and cardiac output), and increased vagal activity decreases heart activity (heart rate).
  • Activity in the sympathetic and vagal nerves is usually antagonistic, and the heart is stably controlled to maintain an appropriate resting heart rate, approximately 70 beats Z minutes. That is, when the sympathetic nerve is nervous, it acts on the heart excitably, whereas when the vagus nerve is nervous, it acts on the heart in a depressing manner.
  • the cardiac therapy device includes a sensor for detecting neural activity that transmits information from the autonomic nervous system to the heart and a comparator with a threshold that forms a condition for the presence of an arrhythmia. Is output depending on whether or not the neural activity matches the condition.
  • a comparator with a threshold that forms a condition for the presence of an arrhythmia. Is output depending on whether or not the neural activity matches the condition.
  • the vagus nerve immediately upon detecting chronic fibrillation or other dangerous tachyarrhythmias from changes in the activity of the autonomic nervous system, it activates the vagus nerve lightly for 5 seconds. Treatment is terminated when a return to the normal state is detected, but when an abnormal condition to the heart is continuously detected, treatment is continued, and a star-shaped sympathetic nerve is added if the sympathetic nerve block is advantageous. It is performed for several seconds in the ganglion.
  • This device for treating cardiac arrhythmias is intended to prevent or stop cardiac arrhythmias and maintain proper heart function through stimulation of heart tissue and vagus nerve.
  • This cardiac therapy device not only compares the pre-set tachycardia detection interval threshold with the patient's pulsation, but also changes the ST portion (voltage) of the electrocardiogram suggesting acute myocardial ischemia.
  • We also examined other factors related to ventricular tachycardia By stimulating the vagus nerve on the basis of this, it is possible to suppress tachycardia.
  • the cardiac arrhythmia treatment device includes a means for continuously measuring an electrocardiogram of a patient's heart, a means for detecting a characteristic of the electrocardiogram indicating tachycardia, a means for initializing a memory of a series of characteristics, and one or more Means for providing electrical stimulation to the patient's nervous system, and means for initializing a series of characteristics of the electrocardiogram following delivery of the stimulation action.
  • Patent Document 1 Japanese Patent Application Laid-Open No. Hei 8 — 5 2 121
  • Patent Document 1 The technique described in Patent Document 1 is to address this problem, and when the activation current is supplied to the vagus nerve and the sympathetic nerve, the cardiac activity falls below a predetermined rate. Automatically starts stimulation of the heart, but the above-mentioned predetermined rate, which is the lower limit of the heart rate, can be maintained, but the rapid heart rate in the process of reaching the predetermined rate after vagal nerve stimulation is reached. It was not possible to avoid the drop in numbers, and the above problems could not be solved.
  • Patent Document 2 stimulates the vagus nerve in order to overcome the decrease in heart rate accompanying the stimulation of the vagus nerve, and stimulates the heart so that the patient's heart rate falls within an allowable range.
  • the lower limit of the heart rate can be maintained by the heart stimulation, as in the case of Patent Document 1, a sudden heart reaching the lower limit of the heart rate is provided. It was not possible to avoid a decrease in the heart rate, and it did not solve the problem of patient discomfort, discomfort, and susceptibility to arrhythmia.
  • an object of the present invention is to control cardiac stimulation so that a decrease in heart rate is within a predetermined range after vagal nerve stimulation, and to prevent a rapid decrease in heart rate due to vagal nerve stimulation.
  • a heart treatment apparatus relates to a nerve stimulating means for stimulating a vagus nerve, a heart contraction detecting means for detecting a heart self-contraction, and a self-contraction.
  • Heart rate measuring means for measuring the heart beat based on the detection result; heart stimulating means for stimulating the heart when no heart self-contraction is detected within a predetermined period; and heart rate measuring the heart beat
  • Heart rate comparing means for comparing the output with a predetermined heart rate threshold value; and determining whether or not to perform vagus nerve stimulation based on the output of the heart rate comparing means. The control is performed so as to be changed based on the measured heart rate output.
  • the measured heartbeat output is a heartbeat interval
  • the control for changing the predetermined period adds a predetermined time increment to the measured heartbeat interval. It is a feature.
  • the predetermined time increment is a fixed time interval, or the predetermined time increment corresponds to a fixed decrease in heart rate. It is characterized by
  • the predetermined time interval is a function of the measured heartbeat interval, and the function is a predetermined ratio of the measured heartbeat interval.
  • the heart treatment device of the present invention has a limit value, and the predetermined period is adjusted so as not to exceed this limit value.
  • the heart treatment method of the present invention includes a step of detecting the heart's self-contraction, a step of measuring the heart beat from the detection result related to the self-contraction, and a step of detecting the heart's self-contraction within a predetermined period. Stimulating the heart if not detected, comparing the heart rate output of the detected heart beat with a predetermined heart rate threshold, and performing vagal nerve stimulation based on the result of the comparison step A step of determining whether or not the vagus nerve is stimulated in the determination step based on the measured heart rate output during a predetermined period. I have.
  • the measured heartbeat output is a heartbeat interval
  • the step of changing the predetermined period based on the measured heartbeat output includes setting the measured heartbeat interval in advance. It is characterized by adding time and minutes.
  • the predetermined time increment is a fixed time interval or a fixed time interval corresponding to a decrease in heart rate.
  • the predetermined time increment is a function of the measured heartbeat interval, and the function is a predetermined ratio of the measured heartbeat interval. I have.
  • the heart stimulation is controlled such that the change in heart rate falls within a predetermined range after vagal nerve stimulation, it is possible to prevent a rapid change in heart rate due to vagus nerve stimulation. Become. BRIEF DESCRIPTION OF THE FIGURES
  • FIG. 1 is a block diagram showing a configuration example of a first embodiment of the heart treatment apparatus of the present invention.
  • FIG. 2 is an arrangement diagram of the electrode lead and the stimulating electrode used in the heart treatment apparatus of the present invention on the heart.
  • FIG. 3 is a flowchart for explaining the operation of the first embodiment of the heart treatment apparatus of the present invention shown in FIG.
  • FIG. 4 is a block diagram showing a configuration example of a second embodiment of the heart treatment apparatus of the present invention.
  • FIG. 5 is a flowchart for explaining the operation of the second embodiment of the heart treatment apparatus of the present invention shown in FIG.
  • FIG. 6 is a timing chart showing the relationship between the vagus nerve stimulation and the ventricular stimulation interval in the second embodiment of the present invention shown in FIG. 4 ⁇ FIG. 7 shows the atria shown in FIG. 1 and FIG. FIG. 10 is a block diagram showing a first modified example of the Z ventricular stimulation interval control means.
  • FIG. 8 is a block diagram showing a second modification of the atrial Z ventricular stimulation interval control means shown in FIGS. 1 and 4.
  • the term “event” of the heart is a general term for spontaneous contractions detected in the atrium or ventricle and contractions caused by stimulating the atrium or ventricle. is there.
  • the heart treatment device 1 of the present invention comprises a stimulus signal to the right ventricle 22 of the heart 21.
  • Ventricular stimulator 2 that generates a signal
  • a ventricular contraction detector 3 that detects contraction of the right ventricle 2 2
  • an atrial stimulator 4 that generates a stimulus signal to the right atrium 23 of the heart 2 1, and a right atrium 2 3
  • an atrial contraction detection unit 5 for detecting contraction
  • a nerve stimulation unit 6 for generating a nerve stimulation signal for stimulating the vagus nerve 26
  • a control unit 7 for controlling the interval between nerve stimulation and atrial stimulation, and an atrial contraction.
  • An OR circuit 8 that supplies the detected signal and a signal that triggers atrial stimulation, a heart rate measurement unit 9 that receives the output of the OR circuit 8 and measures the heartbeat interval, and also supplies an output of the OR circuit 8
  • An atrial stimulation interval timer 10 that is reset and started to measure time; a comparing unit 11 that compares the time measured by the atrial stimulation interval timer 10 with the atrial stimulation interval set by the control unit 7; Control the setting of the vagal nerve 26 stimulation and atrial stimulation intervals
  • Heartbeat threshold storage unit 12 that stores the heartbeat interval threshold of the heartbeat, and a heartbeat comparison unit 13 that compares the heartbeat interval measurement value measured by the heartbeat measurement unit 9 with the heartbeat interval threshold stored in the heartbeat threshold storage unit 12
  • an atrioventricular delay timer 14 that starts at the output of the OR circuit 8 and stops at the output of the ventricular contraction detection unit 3, and stores an atrioventricular delay set value that stores a predetermined atrioventricular delay time. It comprises a unit 15 and an atri
  • the ventricular stimulating unit 2 and the ventricular contraction detecting unit 3 are connected to the ventricular stimulating and detecting electrode 18 by a common ventricular electrode lead 17, and the atrial stimulating unit 4 and the atrial contraction detecting unit 5 similarly have the atria. It is connected to an atrial stimulation detection electrode 20 via an electrode lead 19. Ventricular stimulation detecting electrode 18 and atrial stimulation ⁇ detecting electrode 20 are arranged in right ventricle 22 and right atrium 23 of heart 21, respectively.
  • electrodes for the heart include a myocardial electrode implanted in the heart muscle, so-called myocardium, and a catheter electrode for inserting the electrode through the vena cava to the heart.
  • Figure 2 shows the catheter electrode
  • both the ventricular electrode lead 17 and the atrial electrode lead 19 are initially directed from the vena cava to the right atrium 23 of the heart 21.
  • An atrial electrode lead 19 inserted from the vena cava into the right atrium 23 hooks the tip bent in a J-shape into a bag-shaped right atrial appendage protruding from the wall of the right atrium 23.
  • the atrial stimulation / detection electrode 20 is arranged so as to contact the inner wall of the right atrial appendage.
  • the ventricular electrode lead 17 which enters the right atrium 23 from the vena cava enters the right ventricle 22 through the atrioventricular valve, and is provided at the distal end of the ventricular electrode lead 17.
  • Stimulation / detection electrode 18 is placed in contact with the bottom of right ventricle 22.
  • the nerve stimulating unit 6 is connected to the nerve stimulating electrode 25 via the nerve electrode lead 24, and the nerve stimulating electrode 25 is wound around the vagus nerve 26.
  • the region around which the nerve stimulation electrode 25 is wound is preferably the neck region or the right central position of the lateral carotid artery.
  • the nerve stimulation electrode 25 can be arranged so as to stimulate the vagus nerve 26 adjacent to the blood vessel wall by placing a catheter electrode in the blood vessel. In that case, the subclavian vein is preferable as the placement region.
  • the control unit 7 for controlling the atrial stimulation interval and the nerve stimulation is roughly divided into a neural stimulation signal control unit 27 for controlling the nerve stimulation unit 6 and an atrial stimulation interval control unit 28 for controlling the atrial stimulation interval.
  • Consists of The atrial stimulation interval control unit 28 stores a limit value as an upper limit of the predetermined atrial stimulation interval, and a fixed time of the predetermined atrial stimulation interval.
  • An increment value storage section 30 for storing the increment; an addition section 31 for adding the time increment stored in the increment value storage section 30 to the heartbeat interval measurement value output from the heart rate measuring means 9; 1 is compared with the limit value of the atrial stimulation interval stored in the limit value storage unit 29 in advance, and the upper limit of the output of the adder unit 31 is limited to the limit value.
  • the output of the limit value limiter 32, the limit value memory 29, the limit value limiter 32 and the heart rate comparator 13 is supplied, and based on the output of the heart rate comparator 13 the limit value memory is 29 and an atrial stimulation interval setting unit 33 that finally selects and sets the atrial stimulation interval from the output of the limit value limiting unit 32.
  • the atrial contraction detecting unit 5 detects the contraction of the right atrium 23
  • the atrial contraction detecting unit 5 supplies the output to the OR circuit 8 and also outputs the neural stimulation signal control unit 2 of the control unit 7.
  • Supply 7 As described above, the output of the OR circuit 8 is supplied to the heart rate measuring unit 9, the atrial stimulation interval timer 10 and the atrioventricular delay timer 14, and the heart rate measuring unit 9, the atrial stimulation interval timer 10 and the atrial The timer (time measurement) of the room delay timer 14 is started.
  • the heart rate measurement unit 9 measures the atrial heart rate interval (event interval) from an atrial event (atrial contraction detection or atrial stimulation) to the next atrial event (atrial contraction detection or atrial stimulation). Then, the heartbeat comparison unit 13 compares the heartbeat interval measured by the heartbeat measurement unit 9 with a heartbeat interval threshold stored in the heartbeat threshold storage unit 12 (for example, a heartbeat interval of 750 ms corresponding to a heart rate of 80). When the measured heartbeat interval falls below this threshold, that is, when the heart rate exceeds 80, an output is obtained from the heartbeat comparison unit 13 and the neural stimulation signal control unit 27 of the control unit 7 and the atrial stimulation It is supplied to the atrial stimulation interval setting section 33 of the interval control section 28.
  • a heartbeat interval threshold stored in the heartbeat threshold storage unit 12
  • the output from the atrial contraction detection unit 5 is also supplied to the nerve stimulation signal control unit 27 in addition to the output from the heartbeat comparison unit 13, and the output of the heartbeat comparison unit 13 is received because the heartbeat interval is shortened Activates the neural stimulation signal control unit 27 in relation to the detection of atrial contraction and stimulates the vagus nerve 26 To the nerve stimulating unit 6 as a trigger signal. Then, upon receiving this signal, the nerve stimulating section 6 stimulates the vagus nerve 26 with the nerve electrode lead 24 and the nerve stimulation electrode 25.
  • the heart rate drops sharply, which may increase the incidence of fatal arrhythmias.
  • the heartbeat interval measured by the heart rate measurement unit 9 increases. That is, since the measured value of the heart rate measuring unit 9 becomes longer than the threshold value of the heart rate threshold value storage unit 12 due to the decrease in the heart rate, no output is obtained from the heart rate comparing unit 13. Therefore, a signal for stimulating the vagus nerve 26 is not supplied from the heartbeat comparison unit 13 to the nerve stimulation signal control unit 27, and the vagus nerve 26 is not stimulated.
  • the output of the heart rate measurement unit 9 is supplied to the addition unit 31 of the atrial stimulation interval control unit 28, where the heart rate interval measured by the heart rate measurement unit 9 and the increment value storage unit 30 are stored in advance.
  • the fixed time increment that has been added is added.
  • the added time interval is sent to the limit value limiting unit 32 and compared with the limit value of the atrial stimulation interval stored in the limit value storing unit 29.
  • the new operation value is supplied to the atrial stimulation interval setting unit 33. Is done.
  • the atrial stimulation interval setting unit 33 is supplied with the limit value stored in the limit value storage unit 29 and the signal from the heartbeat comparison unit 13 in addition to the new calculated value.
  • the new calculated value is supplied from the atrial stimulation interval setting unit 33 to the comparison unit 11 as a threshold value for the atrial stimulation interval timer 10.
  • the heartbeat interval exceeds the threshold value (the heart rate is 80 or less)
  • the new calculated value is not selected and the limit value stored in the limit value storage unit 29 is replaced with the atrial stimulation interval timer 10.
  • the threshold value is output to the atrial stimulation interval setting unit 33 and supplied to the comparison unit 11.
  • the output of the atrial contraction detecting section 5 is sent to the atrioventricular delay timer 14 via the OR circuit 8, and the atrioventricular delay timer 14 is started.
  • the time value of the atrioventricular delay timer 14 exceeds a predetermined set value stored in the atrioventricular delay set value storage section 15, an output is obtained from the atrioventricular delay comparison section 16 and Ventricular stimulation is performed by the ventricular stimulator 2.
  • the ventricle contraction detecting unit 3 detects the ventricular contraction before the time value of the atrioventricular delay timer 14 reaches the set value stored in the atrioventricular delay set value storage unit 15, The delay timer 14 stops counting and no ventricular stimulation is performed.
  • FIG. 3 is a flowchart for explaining the operation of the first embodiment of the present invention.
  • the limit value stored in the limit value storage unit 29 of the atrial stimulation interval control unit 28 is set to, for example, a heartbeat interval of 1000 ms corresponding to a heart rate of 60.
  • a heartbeat interval of 1000 ms corresponding to a heart rate of 60.
  • 1000 ms set in the limit value storage unit 29 is supplied to the comparison unit 11 as the output of the atrial stimulation interval setting unit 33 ( Step S l).
  • the atrial stimulation interval timer 10 is started (step S2), and subsequently, the atrial contraction detecting section 5 determines whether or not atrial contraction is detected (step S3). If an atrial contraction is detected in the determination step S3, the heartbeat measurement unit 9 starts measuring the heartbeat interval, that is, measuring the atrial event interval (step S4), and performs atrial stimulation. The interval timer 10 is reset (step S5). Next, in the heart rate comparison unit 13, the atria measured by the heart rate measurement unit 9 It is determined whether the event interval is larger or smaller than a threshold previously stored in the heartbeat threshold storage unit 12, for example, a heartbeat interval of 750 ms corresponding to a heart rate of 80 (step S6).
  • the atrial event interval is, for example, 625 ms and is smaller than the threshold value of 750 ms (that is, when the heart rate exceeds 80)
  • an output is obtained from the heart rate comparing unit 13
  • the output is sent to the nerve stimulation signal control unit 27 to stimulate the vagus nerve 26 (step S7).
  • the atrial event interval measured by the heart rate measuring unit 9 is supplied to the adding unit 31 of the atrial stimulating interval control unit 28, where the measured value of the atrial event interval is stored in the partial value storage unit 30.
  • a fixed time increment, for example, 100 ms, stored in the memory is added (step S8).
  • the limit value limiter 32 it is determined whether or not the calculated value 725ms (625ms + 100ms) added in step S8 is larger than the limit value 1000ms previously stored in the limit value storage unit 29. It is determined (step S9). As in this case, in the determination step S9, the calculated value 725ms to which the time increment is added by the adding unit 31 is smaller than the limit value 1000ms stored in the previously set limit value storage unit 29.
  • the new calculated value is sent from the limit value limiting section 32 to the atrial stimulation interval setting section 33, and the atrial stimulation interval setting section 33 outputs the output of the heart rate comparing section 13 generated in step S6.
  • Atrial event interval 625 ms is smaller than threshold 750 ms
  • a new calculated value is supplied to comparator 11 as a threshold for atrial stimulation interval timer 10 (step S 10).
  • step S6 if the atrial event interval measured by the heart rate measuring unit 9 is equal to or greater than the heartbeat interval threshold 750ms stored in the heartbeat threshold storage unit 12 (heart rate is 80 or less), and If the calculated value obtained by adding the time increment by the adding unit 31 in the judgment step S 9 is equal to or greater than the limit value 1000 ms stored in the limit value storage unit 29 (heartbeat interval is 900 ms or more, that is, the heart rate is 66 or less) )
  • the limit 1000ms is supplied to the comparison unit 11 as a threshold value for the atrial stimulation interval timer 10 and the process proceeds to the next step (step S11).
  • step S12 it is determined whether or not the atrial stimulation interval timer 10 has timed out (step S12).
  • the atrial stimulation interval timer 10 is timed out, that is, when the time measured by the atrial stimulation interval timer 10 exceeds the limit value (1000 ms) of the atrial stimulation interval set in step S 1 (heart rate) (Equation 60 ⁇ or less) is output from the comparing section 11 to the atrial stimulating section 4 to perform atrial stimulation (step S13).
  • the output of the comparison unit 11 is supplied to the heart rate measurement unit 9 via the OR circuit 8, and the measurement of the atrial event interval is started (step S14). It is sent to interval timer 10 and reset (step S15).
  • Step S16 it is determined whether the atrial event interval measured by the heart rate measurement unit 9 is smaller than the heartbeat interval threshold value 750ms set in the heartbeat threshold value storage unit 12 or not. If the measured value of the atrial event interval is stored in the above-mentioned heartbeat threshold storage unit 12 and it is determined that the heartbeat interval threshold is smaller than 750 ms and the heart rate is more than 80, the process proceeds to step S 8. Hereafter, the processing after step S9 is performed. In the determination step S16, if the measured value of the atrial event interval measured by the heart rate measuring unit 9 is equal to or longer than the heartbeat interval threshold value 750ms stored in the heart rate threshold value storage unit 12, the atrial stimulation interval is initially set. The limit value stored in the limit value storage unit 29 remains 1000 ms (step S17), and the process proceeds to the next step.
  • the detected signal or the stimulating signal passes through the OR circuit 8 and the atrioventricular delay timer 14 To start the time measurement of the atrioventricular delay timer 14 (step S18). Then, it is determined whether or not the ventricle contraction is detected by the ventricle contraction detection unit 3 (step S19). If a ventricular contraction is detected in the decision step S19, the atrioventricular delay timer 14 stops counting (step S20) and returns to the decision step S3.
  • step S 19 determines whether the atrioventricular delay timer 14 has timed out, that is, the time measured by the atrioventricular delay timer 14, the atrioventricular delay set value storage unit It is determined whether the set value stored in 15 has been exceeded (step S21). Then, when it is determined in the determination step S21 that the atrioventricular delay timer 14 has not timed out, the flow returns to the determination step S19, and when the atrioventricular delay timer 14 has timed out, An output is output from the atrioventricular delay comparing section 16 to the ventricular stimulating section 2 to perform ventricular stimulation (step S22).
  • the stimulation of the vagus nerve 26 is controlled based on the detection of atrial contraction, and the atrial stimulation interval is controlled.
  • the detection of ventricular contraction is performed.
  • the heartbeat interval is measured to control the vagus nerve 26 stimulation and the ventricular stimulation interval.
  • the second embodiment of the present invention is different from the first embodiment in configuration in that the output of the comparison unit 11 is supplied to the ventricle stimulating unit 2 and the output of the ventricular contraction detecting unit 3 is OR circuit 8 And a point supplied to the nerve stimulation signal control unit 27, and a ventricle stimulation interval control unit 28A and a ventricle instead of the atrial stimulation interval control unit 28 and the atrial stimulation interval setting unit 33 in the first embodiment.
  • the point is that a stimulus interval setting section 33 A is provided.
  • the atrial stimulating unit 4, the atrial contraction detecting unit 5, the atrioventricular delay timer 14, the atrioventricular delay setting value storage unit 15, the atrioventricular delay comparing unit 16 is from the second embodiment Has been deleted.
  • the limit value to be stored in the limit value storage unit 29 of the ventricular stimulation interval control unit 28A is set to, for example, a heartbeat interval 1000 ms corresponding to a heart rate 60.
  • a heartbeat interval 1000 ms corresponding to a heart rate 60.
  • the ventricular stimulation interval timer 10A is started (step S32), and subsequently, the ventricular contraction detector 3 determines whether or not ventricle contraction is detected (step S33). ). If a ventricular contraction is detected in the determination step S33, the heartbeat measuring unit 9 starts measuring the heartbeat interval, that is, measuring the ventricular event interval (step S34), and performs the ventricular stimulation.
  • the interval timer 10A is reset (step S35).
  • step S36 it is determined whether or not the ventricular event interval (heartbeat interval) measured by the heartbeat measurement unit 9 has reached the heartbeat interval threshold 750 ms set in the heartbeat threshold storage unit 12 (step S36).
  • the ventricular event interval is smaller than the threshold value 750 ms (heart rate is 80 or more)
  • an output is obtained from the heart rate comparison unit 13, and this output is output to the nerve stimulation signal control unit 27.
  • the vagus nerve 26 is stimulated (step S37).
  • the ventricular event interval measured by the heart rate measurement unit 9 is supplied to the addition unit 31 of the ventricular stimulation interval control unit 28A, and the measured value of the ventricular event interval is stored in the increment value storage unit 30.
  • the stored fixed time 100 minutes is added (step S38). Then, in the limit value limiting section 32, it is determined whether or not the calculated value added in step S38 is smaller than the limit value 1000ms stored in advance in the limit value storing section 29. W
  • step S39 if it is judged that the calculated value obtained by adding the time and the minute by the adding unit 31 is smaller than the limit value 1000ms stored in the previously set limit value storage unit 29, The new calculated value is sent from the limit value limiting unit 32 to the ventricular stimulation interval setting unit 33A, and the ventricular stimulation interval setting unit 33A outputs the heart rate comparison unit 13 generated in step S36. The output is obtained (the ventricular event interval is smaller than the heartbeat interval threshold), and the new calculated value is supplied to the comparison unit 11 as a threshold for the ventricular stimulation interval timer 1 OA (step S40). . '
  • the determination step S36 if the ventricular event interval measured by the heart rate measurement unit 9 is larger than the heartbeat interval threshold value 750ms stored in the heart rate threshold storage unit 12 (heart rate is 80 or less), In addition, when the calculated value obtained by adding the time increment in the adding unit 31 in the judgment step S39 is larger than the limit value 1000ms stored in the limit value storing unit 29 (heartbeat interval 900ms or more, that is, If the heart rate is 66 or less, the limit value 1000 ms is continuously supplied to the comparison unit 11 as a threshold value for the ventricular stimulation interval timer 10 A, and the process proceeds to the next step (step S 41).
  • step S42 it is determined whether ventricular stimulation interval timer 10A has timed out. If the ventricular stimulation interval timer 10A has timed out, that is, if the time measured by the ventricular stimulation interval timer 10A exceeds the limit value 1000ms of the ventricular stimulation interval set in step S31, An output is output from the comparator 11 to the ventricular stimulator 2 to perform ventricular stimulation (step S43). At the same time, the output of the comparison unit 11 is supplied to the heart rate measurement unit 9 via the OR circuit 8, and the measurement of the ventricular event interval is started (step S44). It is sent to the interval timer 1 OA and reset (step S45).
  • Step S4 6 it is determined whether or not the ventricular event interval measured by the heart rate measuring unit 9 is smaller than the heartbeat interval threshold value 750ms set in the heartbeat threshold value storage unit 12 (Ste S4 6). If it is determined that the measured ventricular event interval is smaller than the heartbeat interval threshold value 750 ms stored in the heartbeat threshold value storage unit 12, the process proceeds to step S 38, and thereafter, proceeds to step S 39. The following processing is performed.
  • determination step S46 if it is determined that the atrial event interval measured by the heart rate measurement unit 9 is larger than the heartbeat interval threshold 750ms stored in the heart rate threshold storage unit 12, the ventricular stimulation interval is set first.
  • the limit value (1000 ms) stored in the stored limit value storage unit 29 is supplied to the comparison unit 11 (step S47), and the process returns to step S33.
  • FIG. 6 is a timing chart showing the relationship between the vagus nerve stimulation and the ventricular stimulation interval in the second embodiment of the present invention shown in FIG. 4, the ventricular stimulation interval limit value 1000 ms, the heartbeat interval threshold value 750 ms, and the time.
  • An example is shown in which ventricular stimulation and vagal stimulation are controlled in increments of 100 ms. ( If atrial stimulation is used instead of ventricular stimulation, it can be applied to the first embodiment of the present invention shown in FIG. 1. Needless to say.
  • times VI, V2, V3, V4, and V5 represent times when ventricular stimulation is performed, and times R1 and R2 represent times when ventricular contraction is detected.
  • the ventricular stimulation interval timer 10 A is started together with the ventricular stimulation from the ventricular stimulating unit 2. Since no ventricular contraction was detected during the threshold value of the ventricular stimulation interval of 1000 ms, the ventricular stimulation interval timer 10A was determined to have timed out (limit value of 1000 ms), indicating that ventricular stimulation was performed at time V2. ing. Subsequently, at time R1, 850 ms after the ventricular stimulation is performed at time V2, the contraction of the ventricle is detected, and as a result, the ventricular stimulation interval timer 10A is reset.
  • the ventricle measured by the heart rate measurement unit 9 at this time The event interval is 850 ms, which is larger than the heartbeat interval threshold 750 ms, and the vagus nerve 26 is not stimulated because no output is sent to the nerve stimulation signal control unit 27 from the heartbeat comparison unit 13. .
  • the value of 850 ras is supplied to the adding unit 31 from the heart rate measuring unit 9, and this value is added to the fixed time increment 100 ms of the increment value storing unit 30.
  • the added calculated value 950 ms is sent to the limit value limiting section 32, where it is compared with the limit value 1000 ms stored in the limit value storing section 29.
  • the calculated value 950 ms is smaller than the limit value 1000 ms', the calculated value 950 ms is supplied to the ventricular stimulation interval setting unit 33 A from the limit value limiting unit 32.
  • the output from the heart rate comparing section 13 is supplied to the ventricular stimulation interval setting section 33 A, the ventricular event interval measured by the heart rate measuring section 9 is 850 ms, and the heartbeat interval threshold value is 750 ms. Therefore, no output is obtained from the heart rate comparison unit 13.
  • the ventricular stimulation interval setting unit 33 A selects the limit value 1000 ms of the limit value storage unit 29, and this value is used as the threshold value of the ventricular stimulation interval by the comparison unit 1. Sent to 1.
  • the heart rate is increased, and the contraction of the regenerated ventricle is detected at time R2 625 ms after the detection of the ventricle at time R1.
  • the ventricular stimulation interval timer 10A is reset.
  • the measured ventricular event interval is 625 ms, which is smaller than the heartbeat interval threshold 750 ms, a signal is sent from the heartbeat comparison unit 13 to the nerve stimulation signal control unit 27, and the nerve stimulation unit 6 sends the signal to the vagus nerve. 26 stimulations are performed.
  • the addition unit 31 adds the time increment 100 ms stored in the increment value storage unit 30 to the ventricular event interval 625 ms from the heart rate measurement unit 9, and the calculated value 725 ms is used as the limit value limiting unit.
  • the calculated value 725 ms is sent to the ventricular stimulation interval setting unit 33 A as a candidate for the next ventricular stimulation interval.
  • the output from the heartbeat comparison unit 13 is sent to the ventricular stimulation interval setting unit 33 A.
  • the ventricular stimulation interval setting unit 33A selects and outputs the calculated value 725ms, and sends it to the comparison unit 11 as a new threshold value of the ventricular stimulation interval.
  • the ventricular stimulation interval timer 10A is reset.
  • the measured ventricular event interval is 725 ms, which is lower than the heartbeat interval threshold 750 ms stored in the heartbeat threshold storage unit 12, so the output from the heartbeat comparison unit 13 is the neural stimulation signal control unit 2. 7, but no stimulation of the vagus nerve 26 occurs because no ventricular contraction is detected by the ventricular contraction detector 3.
  • the measured value 725 ms of the heart rate measuring unit 9 is supplied to the adding unit 31, and the adding unit 31 adds the time / minute 100 ms stored in the increment value storing unit 30 to obtain the calculated value 825 ms. It is sent to the ventricular stimulation interval setting unit 33 A via the limit value limiting unit 32 as a candidate for the ventricular stimulation interval. At this time, since the output of the heart rate comparison unit 13 is added to the ventricular stimulation interval setting unit 33 A, the output of the ventricular stimulation interval setting unit 33 A is a calculated value of 825 ms, and this value is a new ventricular stimulation. It is supplied to the comparison means 11 as the interval threshold.
  • the ventricular stimulation interval timer 10 A is reset. Heartbeat at this time Since the ventricular event interval 825 ms measured by the measurement unit 9 is larger than the heartbeat interval threshold 750 ms, there is no output from the heartbeat comparison unit 13 and the vagus nerve 26 is not stimulated.
  • the adder 31 adds the above-mentioned ventricular event interval of 825 ms and a fixed time increment of 100 ms, and sends a new calculated value of 925 ms from the limit value limiter 32 to the ventricular stimulation interval setting unit 33 A. Since the output from the heartbeat comparison unit 13 is not given to the stimulation interval setting unit 33A, the ventricular stimulation interval setting unit 33A selects the limit value 1000ms stored in the limit value storage unit 29, Send to comparison part 1 1. That is, the threshold of the ventricular stimulation interval returns to the limit value of 1000 ms. If no ventricular contraction is detected during 1000 ms from time V4 to time V5, the ventricular stimulation interval timer 10A times out and ventricular stimulation is performed.
  • FIG. 7 shows a first modification of the atrial stimulation interval control unit 28 and the ventricular stimulation interval control unit 28A in the first embodiment and the second embodiment of the present invention shown in FIGS. 1 and 4.
  • FIG. This modification shows the atrial Z ventricular stimulus interval control unit (28, 28A) when the time increment is a predetermined ratio of the heartbeat interval.
  • an increment ratio storage section 34 and an increment value calculation section 35 are provided instead of the increment value storage section 30 in FIGS.
  • an increment rate of 20% is set in the segment ratio storage section 34.
  • the increment value calculating section At 35 a time increment of 120ms is calculated by multiplying the value of 600ms from the heart rate measurement unit 9 by 20%. Then, the value of 600 ms from the heart rate measurement unit 9 and the value of 120 ms from the increment value calculation unit 35 are added in the addition unit 31, and a value of 720 ms is output to the limit value restriction unit 32.
  • Limit value control section 32 compares the value of 720 ms with a fixed value of 1000 ms stored in advance in the limit value storage unit 29.
  • the new calculated value is 720 ms and the threshold value is smaller than the limit value of 1000 ms, so the new calculated value is output from the limit value control unit 32 and the atrial / ventricular stimulation interval setting units 3 3 and 3 3 Sent to A.
  • the atrial / ventricular stimulation interval control units 33, 33 A select this new calculated value 720 ms and set it to the new threshold value of the atrial or ventricular stimulation interval. This is supplied to the comparison unit 11.
  • FIG. 8 like FIG. 7, shows the atrial stimulation interval control unit 28 and the ventricular stimulation interval control unit 28 in the first embodiment and the second embodiment of the present invention shown in FIG. 1 and FIG.
  • FIG. 11 is a block diagram showing a second modification of A. This modification shows the atrial Z ventricular stimulation interval controller (28, 28A) when the time increment is a time interval corresponding to a fixed decrease in heart rate.
  • the heart rate conversion unit 36 to which the heart rate interval (atrial event interval or ventricular event interval) is supplied from the heart rate measurement unit 9 and a heart rate decrease of, for example, 20 beats per minute are provided.
  • the set value of the reduced heart rate storage unit 37 is subtracted from the output of the heart rate conversion unit 36, and the subtraction unit 38 and the subtraction unit 3 8
  • a heartbeat interval conversion unit 39 for converting the output into a heartbeat interval is provided.
  • the operation of the atrial / ventricular stimulation interval controller (28, 28A) shown in FIG. 8 will be described below.
  • a heart rate decrease of 20 beats per minute is set. If the event interval of the atrium or ventricle measured by the heart rate measurement unit 9 is 600 ms, this value is supplied to the heart rate conversion unit 36, and the heart rate per minute 100 (60) s / 600ms). Thereafter, the subtraction unit 38 subtracts the heart rate decrease 20 stored in the heart rate decrease storage unit 37 from the heart rate 100 output from the heart rate conversion unit 36, Heart rate 8 A value of 0 is supplied from the subtraction unit 38 to the heartbeat interval conversion unit 39.
  • the heartbeat interval converter 39 converts the heart rate 80 into a heartbeat interval of 750 ms, and supplies this value to the limit value limiter 32.
  • the limit value limiting section 32 compares the value of 750 ms output from the heartbeat interval converting section 39 with the limit value 1000 ms stored in the limit value storing section 29. Since this new calculated value 750 ms is smaller than the limit value 1000 ms of the limit value storage unit 29, the limit value limiting unit 32 sends the new calculated value 750 ms to the atrial Z ventricular stimulation interval setting units 33, 33A. . At this time, the atrial / ventricular stimulation interval setting unit 33, 33A receives the output from the heart rate comparison unit 13 and uses the new calculated value 750 ms as the threshold value for the new atrial or ventricular stimulation interval.
  • the first and second embodiments of the present invention and their modifications have been described. However, the present invention is not limited to the above-described embodiments, and is described in the claims. A wide range of embodiments can be adopted without departing from the scope of the present invention.
  • the heart stimulation interval can be adjusted so that the heart rate change after the vagus nerve stimulation falls within a predetermined range, so that the present invention is also used for vagal nerve stimulation.
  • a rapid change in heart rate can be prevented, and a fatal arrhythmia caused by a rapid change in heart rate can be suppressed.

Abstract

A heart treatment device for preventing an abrupt change of heart rate caused by stimulation of a vagus nerve by controlling heart stimulation so that the change of heart rate may be in a predetermined range after the stimulation of the vagus nerve. The heart beat interval is monitored in response to heart stimulation and detection of heart systole. The vagus nerve stimulation is controlled according to the monitored heart beat interval, and the interval of heart stimulation is adjusted so that the heart beat interval extension after the vagus nerve stimulation is limited within a predetermined time interval. Thus, an abrupt drop of heart beat rate due to vagus nerve stimulation for suppressing sympathetic hypertonia and thereby mortal arrhythmia is prevented.

Description

明細書  Specification
心臓治療装置及び心臓治療方法 技術分野  TECHNICAL FIELD OF THE INVENTION
本発明は、 迷走神経刺激に伴う心拍数低下を緩徐化する心臓治 療装置及び心臓治療方法に関する。 背景技術  The present invention relates to a heart treatment device and a heart treatment method for slowing down a heart rate decrease caused by vagal nerve stimulation. Background art
突然死の中で特に心臓病に起因するものを心臓突然死といい、 その数は国内で年間約 5万人にのぼる。 心臓突然死の直接的な原 因は、 致死的不整脈と呼ばれる、 血行動態の破綻をきたす心室頻 拍ゃ心室細動の発生である。  Of the sudden deaths, especially those caused by heart disease, are called sudden cardiac deaths, the number of which is about 50,000 annually in the country. The immediate cause of sudden cardiac death is the development of hemodynamically disrupted ventricular tachycardia—ventricular fibrillation, called lethal arrhythmias.
心室頻拍では心室が発作的に異常に早く拍動し、 心室細動では 心室を構成する個々の筋繊維が無秩序に興奮を始めて心室全体と して小刻みに震えるだけの状態となる。 致死的不整脈が発生する と、 心臓のポンプ機能が低下あるいは消失し、 必要な血液を全身 に送り 出すことができなく なるため、 脳血流の減少に伴う意識消 失をきたし、 直ちに適切な処置を施さなければ死に至ること もあ る。  In ventricular tachycardia, the ventricle pulsates abnormally prematurely, and in ventricular fibrillation, the individual muscle fibers constituting the ventricle begin to excite in a chaotic manner, and the entire ventricle trembles little by little. When a fatal arrhythmia occurs, the pump function of the heart is reduced or lost, and it is impossible to pump the necessary blood to the whole body, causing loss of consciousness due to a decrease in cerebral blood flow. Failure to do so may result in death.
このよ う な心臓突然死のリ ス クを有する患者に対し、 埋め込み 型除細動器( I C D ) を埋め込む治療が行われている。 I C Dは、 心室頻拍ゃ心室細動の発生を検出する と、 心臓に対して電気ショ ックを与えるこ とで、 除細動を行う ものである。 しかしながら、 I C Dは心臓に異常が発生してから動作する、 いわば対処療法の 治療器であり、 また、 除細動のための大きな電気ショ ックが心臓 の組織に損傷を与える恐れがある。  Implantable cardioverter defibrillators (ICD) are being used to treat patients with such a risk of sudden cardiac death. ICD performs defibrillation by giving an electric shock to the heart when the occurrence of ventricular tachycardia / ventricular fibrillation is detected. However, ICD is a so-called coping therapy device that operates after a heart abnormality has occurred, and a large electric shock for defibrillation may damage heart tissue.
と ころで、 心臓活動は、 自律神経系の支配を受けるが、 自律神 経系には交感神経系と副交感神経系があり、 心臓の副交感神経系 は迷走神経である。 交感神経の活動が高まる (緊張する) と心活 動 (心拍数及び心拍出量) が上昇し、 迷走神経の活動が高まる と 心活動 (心拍数) は低下する。 交感神経及ぴ迷走神経における活 動は、 通常拮抗しており、 心臓は適切な静止時心拍、 約 70拍 Z分 を維持するよ う に安定的に制御されている。 すなわち、 交感神経 が緊張する と心臓に対して興奮的に作用するのに対し、 迷走神経 が緊張する と心臓に対して抑制的に作用する。 At this point, cardiac activity is governed by the autonomic nervous system, but the autonomic nervous system has a sympathetic nervous system and a parasympathetic nervous system. Is the vagus nerve. Increased (strained) sympathetic activity increases heart activity (heart rate and cardiac output), and increased vagal activity decreases heart activity (heart rate). Activity in the sympathetic and vagal nerves is usually antagonistic, and the heart is stably controlled to maintain an appropriate resting heart rate, approximately 70 beats Z minutes. That is, when the sympathetic nerve is nervous, it acts on the heart excitably, whereas when the vagus nerve is nervous, it acts on the heart in a depressing manner.
このよ う な作用を利用して、 最近、 迷走神経の電気刺激を行う ことによ り心室性不整脈を治療する心臓治療装置が提案されてい る (例えば、 特許文献 1参照)。 この心臓治療装置は、 自律神経系 から心臓への情報を伝達する神経活動を検知するためのセンサと 不整脈の存在に対する条件を形成する閾値を備えたコンパレータ を有し、 このコンパレータは、 不整脈の発生を示す出力信号を神 経活動が条件に一致するか否かに依存して出力する。 すなわち、 自律神経系の活動の変化などから慢性細動またはその他の危険な 頻脈性不整脈を検知する と直ちに、 迷走神経を 5秒間軽く賦活す る。 そして通常状態への戻り を検知すると治療は終了するが、 心 臓に対する異常状態を継続して検知する場合は、 治療を継続し、 追加的に交感神経のプロ ックが有利であれば星状神経節で数秒間 行なう ものである。  Recently, there has been proposed a cardiac treatment apparatus for treating ventricular arrhythmia by performing electrical stimulation of the vagus nerve using such an action (for example, see Patent Document 1). The cardiac therapy device includes a sensor for detecting neural activity that transmits information from the autonomic nervous system to the heart and a comparator with a threshold that forms a condition for the presence of an arrhythmia. Is output depending on whether or not the neural activity matches the condition. In other words, immediately upon detecting chronic fibrillation or other dangerous tachyarrhythmias from changes in the activity of the autonomic nervous system, it activates the vagus nerve lightly for 5 seconds. Treatment is terminated when a return to the normal state is detected, but when an abnormal condition to the heart is continuously detected, treatment is continued, and a star-shaped sympathetic nerve is added if the sympathetic nerve block is advantageous. It is performed for several seconds in the ganglion.
また、 致死的不整脈を防ぐために、 迷走神経に電気的刺激を加 える方法及び装置が提案されている (例えば、 特許文献 2参照)。 この心臓不整脈を治療する装置は、 心臓組織への刺激と迷走神経 への刺激を通じて、 心臓不整脈の予防あるいは停止と、 心臓の適 切な機能を維持することを目的と している。この心臓治療装置は、 予め設定される頻拍の検出間隔閾値と、 患者の拍動を比較するだ けでなく 、 急性の心筋虚血を示唆する心電図の S T部分 (電圧) の変化と複雑な心室の頻拍に関連する他の要因も精査し、 これに 基づいて迷走神経への刺激を行う こ とによって頻拍を抑制するこ とを可能と している。 この心臓不整脈治療装置は、 患者の心臓の 心電図を連続的に測定する手段、 該心電図の頻拍を示す特徴を検 出する手段、 一連の特性の記憶をイニシャライズする手段、 1個 ないしそれ以上の電気的刺激を患者の神経システムに供給する手 段、 該刺激行為の供給に続く心電図の一連の特性をィニシャライ ズする手段からなっている。 In addition, a method and apparatus for applying electrical stimulation to the vagus nerve to prevent fatal arrhythmias have been proposed (for example, see Patent Document 2). This device for treating cardiac arrhythmias is intended to prevent or stop cardiac arrhythmias and maintain proper heart function through stimulation of heart tissue and vagus nerve. This cardiac therapy device not only compares the pre-set tachycardia detection interval threshold with the patient's pulsation, but also changes the ST portion (voltage) of the electrocardiogram suggesting acute myocardial ischemia. We also examined other factors related to ventricular tachycardia, By stimulating the vagus nerve on the basis of this, it is possible to suppress tachycardia. The cardiac arrhythmia treatment device includes a means for continuously measuring an electrocardiogram of a patient's heart, a means for detecting a characteristic of the electrocardiogram indicating tachycardia, a means for initializing a memory of a series of characteristics, and one or more Means for providing electrical stimulation to the patient's nervous system, and means for initializing a series of characteristics of the electrocardiogram following delivery of the stimulation action.
[特許文献 1 ] 特開平 8 — 5 2 1 2 1号公報  [Patent Document 1] Japanese Patent Application Laid-Open No. Hei 8 — 5 2 121
[特許文献 2 ]  [Patent Document 2]
国際公開第 93/2 1824号パンフ レッ ト ( PCT/US 93/00051 ) 発明の開示  WO 93/21824 Pan fret (PCT / US 93/00051) Disclosure of the Invention
迷走神経への電気刺激は心拍数の低下をもたらすが、 心拍数の 急激な低下は、 患者に対して違和感ゃ不快感を与える と同時に、 興奮の不応期を不安定と して不整脈を起こ しやすくする という問 題があった。  Electrical stimulation of the vagus nerve causes a decrease in heart rate, but a rapid decrease in heart rate causes discomfort and discomfort to the patient, and also causes arrhythmia by making the refractory period of excitement unstable. There was a problem of making it easier.
特許文献 1 に記載のものは、 この問題に対処するためのもので あり、 賦活電流が迷走神経及び交感神経に供給されたこ とで心活 動が所定レー トを下回る場合に、 ペースメーカブロ ックが自動的 に心臓への刺激を開始するものであるが、 心拍数の下限値たる前 記所定レー トを維持できるものの、 迷走神経刺激後の前記所定レ ー トに至る過程での急激な心拍数低下を回避するこ とはできず、 上記問題を解決するこ とができなかった。  The technique described in Patent Document 1 is to address this problem, and when the activation current is supplied to the vagus nerve and the sympathetic nerve, the cardiac activity falls below a predetermined rate. Automatically starts stimulation of the heart, but the above-mentioned predetermined rate, which is the lower limit of the heart rate, can be maintained, but the rapid heart rate in the process of reaching the predetermined rate after vagal nerve stimulation is reached. It was not possible to avoid the drop in numbers, and the above problems could not be solved.
また、 特許文献 2に記載のものは、 迷走神経への刺激に伴う心 拍数低下を克服するために迷走神経を刺激すると共に、 患者の心 拍数が許容範囲内となるよ う に心臓に対して刺激を与えるもので あるが、 心拍数の下限値を心臓刺激によって維持できるものの、 特許文献 1 に記載のものと同様に、 心拍数下限値に至る急激な心 拍数低下を回避するこ とはできず、 患者の違和感ゃ不快感、 さ ら には不整脈を起こ しやすいという問題を解決するには至らなかつ た。 In addition, the one described in Patent Document 2 stimulates the vagus nerve in order to overcome the decrease in heart rate accompanying the stimulation of the vagus nerve, and stimulates the heart so that the patient's heart rate falls within an allowable range. Although the lower limit of the heart rate can be maintained by the heart stimulation, as in the case of Patent Document 1, a sudden heart reaching the lower limit of the heart rate is provided. It was not possible to avoid a decrease in the heart rate, and it did not solve the problem of patient discomfort, discomfort, and susceptibility to arrhythmia.
そこで、 本発明は、 迷走神経刺激後に、 心拍数低下が所定範囲 内となるよ う に心臓刺激を制御し、 迷走神経の刺激による心拍数 の急激な低下を防止することを目的とする。  Therefore, an object of the present invention is to control cardiac stimulation so that a decrease in heart rate is within a predetermined range after vagal nerve stimulation, and to prevent a rapid decrease in heart rate due to vagal nerve stimulation.
上記課題を解決し、 本発明の目的を達成するため、 本発明の心 臓治療装置は、 迷走神経を刺激する神経刺激手段と、 心臓の自己 収縮を検出する心臓収縮検出手段と、 自己収縮に関する検出結果 から心臓の拍動を計測する心拍計測手段と、 予め定めた期間内に 心臓の自己収縮が検出されなかった場合に心臓を刺激する心臓刺 激手段と、 心臓の拍動を計測した心拍出力と予め定めた心拍閾値 を比較する心拍比較手段と、 この心拍比較手段の出力に基づいて 迷走神経刺激を行うか否かを決定し、 迷走神経刺激を行った場合 に、 上記予め定めた期間を計測した心拍出力に基づいて変更する よ う制御すること を特徴とするものである。  In order to solve the above problems and achieve the object of the present invention, a heart treatment apparatus according to the present invention relates to a nerve stimulating means for stimulating a vagus nerve, a heart contraction detecting means for detecting a heart self-contraction, and a self-contraction. Heart rate measuring means for measuring the heart beat based on the detection result; heart stimulating means for stimulating the heart when no heart self-contraction is detected within a predetermined period; and heart rate measuring the heart beat Heart rate comparing means for comparing the output with a predetermined heart rate threshold value; and determining whether or not to perform vagus nerve stimulation based on the output of the heart rate comparing means. The control is performed so as to be changed based on the measured heart rate output.
また、 本発明の心臓治療装置は、 計測した心拍出力が心拍間隔 であ り、 上記予め定めた期間を変更する制御が、 計測した心拍間 隔に予め定めた時間増分を加えるものであることを特徴と してい る。  Also, in the heart treatment apparatus of the present invention, the measured heartbeat output is a heartbeat interval, and the control for changing the predetermined period adds a predetermined time increment to the measured heartbeat interval. It is a feature.
さ らに、 本発明の心臓治療装置の好ましい形態は、 上記予め定 めた時間増分が固定した時間間隔であるか、 あるいは、 上記予め 定めた時間増分が固定した心拍数低下に相当する時間間隔である こ とを特徴と している。  Further, in a preferred embodiment of the heart treatment apparatus according to the present invention, the predetermined time increment is a fixed time interval, or the predetermined time increment corresponds to a fixed decrease in heart rate. It is characterized by
また、 本発明の別の好ま しい形態では、 上記予め定めた時間增 分が計測した心拍間隔の関数であり、 そして、 この関数が計測し た心拍間隔の所定の割合となっていることを特徴と している。  In another preferred aspect of the present invention, the predetermined time interval is a function of the measured heartbeat interval, and the function is a predetermined ratio of the measured heartbeat interval. And
更に、 本発明の心臓治療装置において. 上記予め定めた期間は 限界値を有し、 予め定めた期間がこの限界値を超えるこ とのない よ う に調節されるよ うになっている。 Further, in the heart treatment device of the present invention. It has a limit value, and the predetermined period is adjusted so as not to exceed this limit value.
また、 本発明の心臓治療方法は、 心臓の自己収縮を検出するス テツプと、 この自己収縮に関する検出結果から心臓の拍動を計測 するステップと、 予め定めた期間内に上記心臓の自己収縮が検出 されなかった場合に心臓を刺激するステップと、 心臓の拍動を検 出した心拍出力と予め定めた心拍閾値を比較するステップと、 こ の比較ステップの結果に基づいて迷走神経刺激を行うか否かを決 定するステップ、 を有し、 この決定ステップにおいて迷走神経刺 激を行った場合に、 予め定めた期間を計測した心拍出力に基づい て変更するステップを有するこ とを特徴と している。  In addition, the heart treatment method of the present invention includes a step of detecting the heart's self-contraction, a step of measuring the heart beat from the detection result related to the self-contraction, and a step of detecting the heart's self-contraction within a predetermined period. Stimulating the heart if not detected, comparing the heart rate output of the detected heart beat with a predetermined heart rate threshold, and performing vagal nerve stimulation based on the result of the comparison step A step of determining whether or not the vagus nerve is stimulated in the determination step based on the measured heart rate output during a predetermined period. I have.
そして、 本発明の心臓治療方法の好ま しい形態では、 計測した 心拍出力が心拍間隔であり、 上記予め定めた期間を計測した心拍 出力に基づいて変更するステップが、 計測した心拍間隔に予め定 めた時間增分を加えるものであるこ とを特徴とする。  In a preferred embodiment of the heart treatment method according to the present invention, the measured heartbeat output is a heartbeat interval, and the step of changing the predetermined period based on the measured heartbeat output includes setting the measured heartbeat interval in advance. It is characterized by adding time and minutes.
また、 本発明の好ましい形態と して、 上記予め定めた時間増分 が固定した時間間隔であるか、 あるいは固定した心拍数低下に相 当する時間間隔であるこ とを特徴と している。  In a preferred embodiment of the present invention, the predetermined time increment is a fixed time interval or a fixed time interval corresponding to a decrease in heart rate.
さ らに、 本発明の好ま しい形態と しては、 上記予め定めた時間 増分が計測した心拍間隔の関数であり、 この関数が計測した心拍 間隔の所定の割合であることを特徴と している。  In a preferred embodiment of the present invention, the predetermined time increment is a function of the measured heartbeat interval, and the function is a predetermined ratio of the measured heartbeat interval. I have.
本発明によれば、 迷走神経刺激後に心拍数の変化が所定の範囲 内に収まるよ う に心臓刺激を制御するので、 迷走神経刺激に伴う 心拍数の急激な変化を防止するこ とが可能となる。 図面の簡単な説明  According to the present invention, since the heart stimulation is controlled such that the change in heart rate falls within a predetermined range after vagal nerve stimulation, it is possible to prevent a rapid change in heart rate due to vagus nerve stimulation. Become. BRIEF DESCRIPTION OF THE FIGURES
図 1 は、 本発明の心臓治療装置の第 1 の実施形態の構成例を示 したプロ ック図である。 図 2は、 本発明の心臓治療装置に用いられる電極リー ド及ぴ刺 激電極の心臓への配置図である。 FIG. 1 is a block diagram showing a configuration example of a first embodiment of the heart treatment apparatus of the present invention. FIG. 2 is an arrangement diagram of the electrode lead and the stimulating electrode used in the heart treatment apparatus of the present invention on the heart.
図 3は、 図 1 に示す本発明の心臓治療装置の第 1 の実施形態の 作用を説明するためのフロー図である。  FIG. 3 is a flowchart for explaining the operation of the first embodiment of the heart treatment apparatus of the present invention shown in FIG.
図 4は、 本発明の心臓治療装置の第 2の実施形態の構成例を示 したプロ ック図である。  FIG. 4 is a block diagram showing a configuration example of a second embodiment of the heart treatment apparatus of the present invention.
図 5 は、 図 4に示す本発明の心臓治療装置の第 2の実施形態の 作用を説明するためのフロー図である。  FIG. 5 is a flowchart for explaining the operation of the second embodiment of the heart treatment apparatus of the present invention shown in FIG.
図 6 は、 図 4に示す本発明の第 2の実施形態において、 迷走神 経の刺激と心室刺激間隔の関係を示すタイ ミ ングチャー トである < 図 7は、 図 1及び図 4に示す心房 Z心室刺激間隔制御手段の第 1 の変形例を示すブロ ック図である。  FIG. 6 is a timing chart showing the relationship between the vagus nerve stimulation and the ventricular stimulation interval in the second embodiment of the present invention shown in FIG. 4 <FIG. 7 shows the atria shown in FIG. 1 and FIG. FIG. 10 is a block diagram showing a first modified example of the Z ventricular stimulation interval control means.
図 8 は、 図 1及び図 4に示す心房 Z心室刺激間隔制御手段の第 2の変形例を示すブロ ック図である。 発明を実施するための最良の形態  FIG. 8 is a block diagram showing a second modification of the atrial Z ventricular stimulation interval control means shown in FIGS. 1 and 4. BEST MODE FOR CARRYING OUT THE INVENTION
以下、 本発明の好適な実施の形態を添付図面に基づいて詳細に 説明する。  Hereinafter, preferred embodiments of the present invention will be described in detail with reference to the accompanying drawings.
なお、 以下に述べる実施の形態は、 本発明の好適な具体例であ るから、 技術的に好ましい種々の限定が付されているが、 本発明 の範囲は、 以下の説明において特に本発明を限定する旨の記載が ない限り 、 これらの形態に限られるものではない。  Note that the embodiments described below are preferred specific examples of the present invention, and therefore, various technically preferred limitations are added. However, the scope of the present invention is particularly limited by the following description. It is not limited to these forms unless stated to limit.
まず、 本発明による心臓治療装置の第 1の実施形態を図 1 のプ 口 ック図に基づいて説明する。  First, a first embodiment of the heart treatment apparatus according to the present invention will be described with reference to the block diagram of FIG.
なお、 本明細書において、 心臓の 「イベン ト」 とは、 心房また は心室で検出された自発的な収縮と、 心房または心室に対し刺激 を行う こ とに起因する収縮とを総称したものである。  As used herein, the term “event” of the heart is a general term for spontaneous contractions detected in the atrium or ventricle and contractions caused by stimulating the atrium or ventricle. is there.
本発明の心臓治療装置 1 は、 心臓 2 1 の右心室 2 2への刺激信 号を発生する心室刺激部 2 と、 右心室 2 2 の収縮を検出する心室 収縮検出部 3 と、 心臓 2 1 の右心房 2 3への刺激信号を発生する 心房刺激部 4 と、 右心房 2 3 の収縮を検出する心房収縮検出部 5 と、 迷走神経 2 6 を刺激する神経刺激信号を発生する神経刺激部 6 と、 神経刺激及び心房刺激間隔を制御する制御部 7 と、 心房収 縮を検出した信号及び心房刺激を ト リ ガーする信号が供給される O R回路 8 と、 O R回路 8の出力が供給され心拍間隔の計測を行 う心拍計測部 9 と、 同じく O R回路 8 の出力が供給されてリセッ ト され時間計測を ϋ始する心房刺激間隔タイマ 1 0 と、 心房刺激 間隔タイマ 1 0 の計時時間と制御部 7 において設定される心房刺 激間隔とを比較する比較部 1 1 と、 迷走神経 2 6への刺激及び心 房刺激間隔の設定を制御するための心拍間隔閾値を記憶する心拍 閾値記憶部 1 2 と、 心拍計測部 9で計測された心拍間隔計測値と 心拍閾値記憶部 1 2に記憶された心拍間隔閾値とを比較する心拍 比較部 1 3 と、 O R回路 8 の出力でス ター ト し心室収縮検出部 3 の出力でス ト ップする房室遅延タイマ 1 4 と、 予め定めた房室遅 延時間を記憶する房室遅延設定値記憶部 1 5 と、 房室遅延タイマ 1 4の出力と房室遅延設定値記憶部 1 5 の出力を比較する房室遅 延比較部 1 6 とから構成される。 The heart treatment device 1 of the present invention comprises a stimulus signal to the right ventricle 22 of the heart 21. Ventricular stimulator 2 that generates a signal, a ventricular contraction detector 3 that detects contraction of the right ventricle 2 2, an atrial stimulator 4 that generates a stimulus signal to the right atrium 23 of the heart 2 1, and a right atrium 2 3, an atrial contraction detection unit 5 for detecting contraction, a nerve stimulation unit 6 for generating a nerve stimulation signal for stimulating the vagus nerve 26, a control unit 7 for controlling the interval between nerve stimulation and atrial stimulation, and an atrial contraction. An OR circuit 8 that supplies the detected signal and a signal that triggers atrial stimulation, a heart rate measurement unit 9 that receives the output of the OR circuit 8 and measures the heartbeat interval, and also supplies an output of the OR circuit 8 An atrial stimulation interval timer 10 that is reset and started to measure time; a comparing unit 11 that compares the time measured by the atrial stimulation interval timer 10 with the atrial stimulation interval set by the control unit 7; Control the setting of the vagal nerve 26 stimulation and atrial stimulation intervals Heartbeat threshold storage unit 12 that stores the heartbeat interval threshold of the heartbeat, and a heartbeat comparison unit 13 that compares the heartbeat interval measurement value measured by the heartbeat measurement unit 9 with the heartbeat interval threshold stored in the heartbeat threshold storage unit 12 And an atrioventricular delay timer 14 that starts at the output of the OR circuit 8 and stops at the output of the ventricular contraction detection unit 3, and stores an atrioventricular delay set value that stores a predetermined atrioventricular delay time. It comprises a unit 15 and an atrioventricular delay comparing unit 16 which compares the output of the atrioventricular delay timer 14 with the output of the atrioventricular delay set value storage unit 15.
心室刺激部 2及ぴ心室収縮検出部 3 は、 共通の心室電極リー ド 1 7によ り心室刺激 Ζ検出電極 1 8 に接続され、 心房刺激部 4及 ぴ心房収縮検出部 5 も同様に心房電極リ ー ド 1 9 を介して心房刺 激 検出電極 2 0 に接続されている。 心室刺激 検出電極 1 8 と 心房刺激 Ζ検出電極 2 0は、 心臓 2 1 の右心室 2 2 と右心房 2 3 にそれぞれ配置される。  The ventricular stimulating unit 2 and the ventricular contraction detecting unit 3 are connected to the ventricular stimulating and detecting electrode 18 by a common ventricular electrode lead 17, and the atrial stimulating unit 4 and the atrial contraction detecting unit 5 similarly have the atria. It is connected to an atrial stimulation detection electrode 20 via an electrode lead 19. Ventricular stimulation detecting electrode 18 and atrial stimulation Ζ detecting electrode 20 are arranged in right ventricle 22 and right atrium 23 of heart 21, respectively.
一般に、 心臓用の電極と しては、 心臓の筋肉、 いわゆる心筋内 に埋め込む心筋電極と、 大静脈を経由して心臓まで電極を挿入す るカテーテル電極がある。 図 2に示すものは、 カテーテル電極の 例であるが、 心室電極リー ド 1 7及び心房電極リー ド 1 9 のいず れも最初は大静脈から心臓 2 1 の右心房 2 3 に導かれる。 大静脈 から右心房 2 3 に揷入された心房電極リー ド 1 9 は、 J 字状に曲 げられた先端部を右心房 2 3の壁から出っ張った袋状の右心耳内 に引っ掛けるよ う に揷入し、 心房刺激/検出電極 2 0が右心耳内 壁に接触するよ う に配置される。 また、 同様に大静脈から右心房 2 3 に揷入される心室電極リー ド 1 7は、 房室弁を通って右心室 2 2に入り、 心室電極リー ド 1 7の先端部に設けられる心室刺激 /検出電極 1 8が右心室 2 2の最下部に接触するよ うに配置され る。 Generally, electrodes for the heart include a myocardial electrode implanted in the heart muscle, so-called myocardium, and a catheter electrode for inserting the electrode through the vena cava to the heart. Figure 2 shows the catheter electrode By way of example, both the ventricular electrode lead 17 and the atrial electrode lead 19 are initially directed from the vena cava to the right atrium 23 of the heart 21. An atrial electrode lead 19 inserted from the vena cava into the right atrium 23 hooks the tip bent in a J-shape into a bag-shaped right atrial appendage protruding from the wall of the right atrium 23. Then, the atrial stimulation / detection electrode 20 is arranged so as to contact the inner wall of the right atrial appendage. Similarly, the ventricular electrode lead 17 which enters the right atrium 23 from the vena cava enters the right ventricle 22 through the atrioventricular valve, and is provided at the distal end of the ventricular electrode lead 17. Stimulation / detection electrode 18 is placed in contact with the bottom of right ventricle 22.
また、 図 2には図示されていないが、 神経刺激部 6は神経電極 リー ド 2 4を介して神経刺激電極 2 5 に接続され、 神経刺激電極 2 5 は迷走神経 2 6 に卷きつけた状態で固定される。 神経刺激電 極 2 5 を卷きつける領域と しては、 頸部領域かあるいは外側頸動 脈の右中央位置が好適である。 また、 神経刺激電極 2 5は、 血管 内にカテーテル電極を留置するこ とによって、 血管壁に隣接した 迷走神経 2 6 を刺激するよ うに配置するこ と も可能である。 その 場合、 配置領域と しては、 鎖骨下静脈内が好適である。  Although not shown in FIG. 2, the nerve stimulating unit 6 is connected to the nerve stimulating electrode 25 via the nerve electrode lead 24, and the nerve stimulating electrode 25 is wound around the vagus nerve 26. Fixed at. The region around which the nerve stimulation electrode 25 is wound is preferably the neck region or the right central position of the lateral carotid artery. The nerve stimulation electrode 25 can be arranged so as to stimulate the vagus nerve 26 adjacent to the blood vessel wall by placing a catheter electrode in the blood vessel. In that case, the subclavian vein is preferable as the placement region.
心房刺激間隔及び神経刺激を制御する制御部 7は、 大き く分け て神経刺激部 6 を制御する神経刺激信号制御部 2 7 と、 心房の刺 激間隔を制御する心房刺激間隔制御部 2 8 とから構成される。 そ して、 心房刺激間隔制御部 2 8 は、 予め定めた心房刺激間隔の上 限と しての限界値を記憶する限界値記憶部 2 9 と、 予め定めた心 房刺激間隔の固定の時間増分を記憶する増分値記憶部 3 0 と、 心 拍計測手段 9から出力される心拍間隔計測値に増分値記憶部 3 0 に記憶した時間増分を加算する加算部 3 1 と、 この加算部 3 1 の 出力と限界値記憶部 2 9 に予め記憶されている心房刺激間隔の限 界値とを比較し、 加算部 3 1 の出力の上限を限界値に制限する限 界値制限部 3 2 と、 限界値記憶部 2 9、 限界値制限部 3 2及ぴ心 拍比較部 1 3 の出力が供給され、 心拍比較部 1 3 の出力に基づい て、 限界値記憶部 2 9 と限界値制限部 3 2の出力から最終的に心 房刺激間隔を選択 · 設定する心房刺激間隔設定部 3 3 とから構成 されている。 The control unit 7 for controlling the atrial stimulation interval and the nerve stimulation is roughly divided into a neural stimulation signal control unit 27 for controlling the nerve stimulation unit 6 and an atrial stimulation interval control unit 28 for controlling the atrial stimulation interval. Consists of The atrial stimulation interval control unit 28 stores a limit value as an upper limit of the predetermined atrial stimulation interval, and a fixed time of the predetermined atrial stimulation interval. An increment value storage section 30 for storing the increment; an addition section 31 for adding the time increment stored in the increment value storage section 30 to the heartbeat interval measurement value output from the heart rate measuring means 9; 1 is compared with the limit value of the atrial stimulation interval stored in the limit value storage unit 29 in advance, and the upper limit of the output of the adder unit 31 is limited to the limit value. The output of the limit value limiter 32, the limit value memory 29, the limit value limiter 32 and the heart rate comparator 13 is supplied, and based on the output of the heart rate comparator 13 the limit value memory is 29 and an atrial stimulation interval setting unit 33 that finally selects and sets the atrial stimulation interval from the output of the limit value limiting unit 32.
以下、 図 1 に示す本発明の心臓治療装置の第 1 の実施の形態の 作用について説明する。  Hereinafter, the operation of the first embodiment of the heart treatment apparatus of the present invention shown in FIG. 1 will be described.
まず、 心房収縮検出部 5において、 右心房 2 3 の収縮が検出さ れると、 心房収縮検出部 5は、 その出力を O R回路 8 に供給する と ともに、 制御部 7の神経刺激信号制御部 2 7に供給する。 O R 回路 8 の出力は、 既述したよ う に、 心拍計測部 9、 心房刺激間隔 タイマ 1 0及ぴ房室遅延タイマ 1 4に供給され、 心拍計測部 9 、 心房刺激間隔タイマ 1 0及び房室遅延タイマ 1 4 の計時 (時間計 測) をスター ト させる。  First, when the atrial contraction detecting unit 5 detects the contraction of the right atrium 23, the atrial contraction detecting unit 5 supplies the output to the OR circuit 8 and also outputs the neural stimulation signal control unit 2 of the control unit 7. Supply 7 As described above, the output of the OR circuit 8 is supplied to the heart rate measuring unit 9, the atrial stimulation interval timer 10 and the atrioventricular delay timer 14, and the heart rate measuring unit 9, the atrial stimulation interval timer 10 and the atrial The timer (time measurement) of the room delay timer 14 is started.
すなわち、 心拍計測部 9は心房イベン ト (心房収縮検出または 心房刺激) から次の心房イベン ト (心房収縮検出または心房刺激) までの心房の心拍間隔 (イベン ト間隔) を計時する。 そして、 心 拍比較部 1 3 において、 心拍計測部 9で計測した心拍間隔が心拍 閾値記憶部 1 2 に記憶されている心拍間隔閾値 (例えば、 心拍数 8 0に相当する心拍間隔 750ms ) と比較され、 計測した心拍間隔 がこの閾値を下回ると、 つま り心拍数が 8 0 を超える と、 心拍比 較部 1 3から出力が得られ、 制御部 7 の神経刺激信号制御部 2 7 及び心房刺激間隔制御部 2 8 の心房刺激間隔設定部 3 3 に供給さ れる。  That is, the heart rate measurement unit 9 measures the atrial heart rate interval (event interval) from an atrial event (atrial contraction detection or atrial stimulation) to the next atrial event (atrial contraction detection or atrial stimulation). Then, the heartbeat comparison unit 13 compares the heartbeat interval measured by the heartbeat measurement unit 9 with a heartbeat interval threshold stored in the heartbeat threshold storage unit 12 (for example, a heartbeat interval of 750 ms corresponding to a heart rate of 80). When the measured heartbeat interval falls below this threshold, that is, when the heart rate exceeds 80, an output is obtained from the heartbeat comparison unit 13 and the neural stimulation signal control unit 27 of the control unit 7 and the atrial stimulation It is supplied to the atrial stimulation interval setting section 33 of the interval control section 28.
神経刺激信号制御部 2 7には、 心拍比較部 1 3の出力のほかに、 心房収縮検出部 5からの出力も供給されており、 心拍間隔が短く なって心拍比較部 1 3の出力を受ける と心房収縮の検出と関連さ せて神経刺激信号制御部 2 7 を作動させ、 迷走神経 2 6 を刺激す るための ト リガーとなる信号を神経刺激部 6 に供給する。そして、 神経刺激部 6 はこの信号を受ける と、 神経電極リー ド 2 4、 神経 刺激電極 2 5 によ り、 迷走神経 2 6 の刺激を行う。 The output from the atrial contraction detection unit 5 is also supplied to the nerve stimulation signal control unit 27 in addition to the output from the heartbeat comparison unit 13, and the output of the heartbeat comparison unit 13 is received because the heartbeat interval is shortened Activates the neural stimulation signal control unit 27 in relation to the detection of atrial contraction and stimulates the vagus nerve 26 To the nerve stimulating unit 6 as a trigger signal. Then, upon receiving this signal, the nerve stimulating section 6 stimulates the vagus nerve 26 with the nerve electrode lead 24 and the nerve stimulation electrode 25.
迷走神経 2 6 が刺激される と、 心拍数が急激に低下するので、 逆に致死的不整脈の発生を高くする虞がある。 つま り、 心拍数が 低下すると、 心拍計測部 9 で計測される心拍間隔が長く なる。 す なわち、 心拍数の減少によ り、 心拍計測部 9 の計測値が心拍閾値 記憶部 1 2 の閾値よ り長く なるので、 心拍比較部 1 3からは出力 が得られない。 このため、 心拍比較部 1 3から神経刺激信号制御 部 2 7 に迷走神経 2 6 を刺激するための信号は供給されず、 迷走 神経 2 6 の刺激は行われない。  When the vagus nerve 26 is stimulated, the heart rate drops sharply, which may increase the incidence of fatal arrhythmias. In other words, as the heart rate decreases, the heartbeat interval measured by the heart rate measurement unit 9 increases. That is, since the measured value of the heart rate measuring unit 9 becomes longer than the threshold value of the heart rate threshold value storage unit 12 due to the decrease in the heart rate, no output is obtained from the heart rate comparing unit 13. Therefore, a signal for stimulating the vagus nerve 26 is not supplied from the heartbeat comparison unit 13 to the nerve stimulation signal control unit 27, and the vagus nerve 26 is not stimulated.
また、 心拍計測部 9 の出力は心房刺激間隔制御部 2 8 の加算部 3 1 に供給されており、 ここで、 心拍計測部 9で計測した心拍間 隔と増分値記憶部 3 0 に予め記憶されている固定の時間増分が加 算される。 そして、 上記加算された時間間隔が限界値制限部 3 2 に送られ、 限界値記憶部 2 9に記憶されている心房刺激間隔の限 界値と比較される。 そして、 この時間增分が加算された新たな演 算値が限界値記憶部 2 9 に記憶されている限界値よ り も小さいと き、 新たな演算値が心房刺激間隔設定部 3 3 に供給される。 心房 刺激間隔設定部 3 3 には、 この新たな演算値の他に限界値記憶部 2 9 に記憶されている限界値と心拍比較部 1 3からの信号が供給 されており、 心拍比較部 1 3からの出力がある とき、 すなわち心 拍計測部 9で計測される心拍間隔が心拍閾値記憶部 1 2に記憶さ れている心拍間隔閾値を超えないとき (例えば、 心拍数が 8 0以' 上) は、 上記新たな演算値を、 心房刺激間隔タイマ 1 0に対する 閾値と して、心房刺激間隔設定部 3 3から比較部 1 1 に供給する。 逆に、 心拍比較部 1 3からの出力がないとき、 すなわち心拍計 測部 9 で計測される心拍間隔が心拍閾値記憶部 1 2に記憶されて いる心拍間隔閾値を超えるとき (心拍数が 8 0以下) は、 上記新 たな演算値は選択されず、 限界値記憶部 2 9 に記憶されている限 界値を、 心房刺激間隔タイマ 1 0 に対する閾値と して、 心房刺激 間隔設定部 3 3 へ出力して比較部 1 1 に供給する。 The output of the heart rate measurement unit 9 is supplied to the addition unit 31 of the atrial stimulation interval control unit 28, where the heart rate interval measured by the heart rate measurement unit 9 and the increment value storage unit 30 are stored in advance. The fixed time increment that has been added is added. Then, the added time interval is sent to the limit value limiting unit 32 and compared with the limit value of the atrial stimulation interval stored in the limit value storing unit 29. Then, when the new operation value to which this time is added is smaller than the limit value stored in the limit value storage unit 29, the new operation value is supplied to the atrial stimulation interval setting unit 33. Is done. The atrial stimulation interval setting unit 33 is supplied with the limit value stored in the limit value storage unit 29 and the signal from the heartbeat comparison unit 13 in addition to the new calculated value. When there is an output from 3, that is, when the heartbeat interval measured by the heartbeat measurement unit 9 does not exceed the heartbeat interval threshold stored in the heartbeat threshold storage unit 12 (for example, when the heart rate is 80 or less). In the above, the new calculated value is supplied from the atrial stimulation interval setting unit 33 to the comparison unit 11 as a threshold value for the atrial stimulation interval timer 10. Conversely, when there is no output from the heart rate comparison unit 13, that is, the heartbeat interval measured by the heart rate measurement unit 9 is stored in the heartbeat threshold value storage unit 12. If the heartbeat interval exceeds the threshold value (the heart rate is 80 or less), the new calculated value is not selected and the limit value stored in the limit value storage unit 29 is replaced with the atrial stimulation interval timer 10. The threshold value is output to the atrial stimulation interval setting unit 33 and supplied to the comparison unit 11.
また、 心房収縮検出部 5の出力は O R回路 8 を介して房室遅延 タイマ 1 4 に送られ、 房室遅延タイマ 1 4をス ター ト させる。 こ の房室遅延タイマ 1 4における計時値が、 房室遅延設定値記憶部 1 5に記憶されている予め定めた設定値を超える と、 房室遅延比 較部 1 6から出力が得られ、 心室刺激部 2によ り心室刺激が行わ れる。 一方、 房室遅延タイマ 1 4 の計時値が、 房室遅延設定値記 憶部 1 5に記憶されている設定値に達する前に心室収縮検出部 3 によって心室収縮が検出される と、 房室遅延タイマ 1 4 の計時が ス ト ップし、 心室刺激は行われない。  The output of the atrial contraction detecting section 5 is sent to the atrioventricular delay timer 14 via the OR circuit 8, and the atrioventricular delay timer 14 is started. When the time value of the atrioventricular delay timer 14 exceeds a predetermined set value stored in the atrioventricular delay set value storage section 15, an output is obtained from the atrioventricular delay comparison section 16 and Ventricular stimulation is performed by the ventricular stimulator 2. On the other hand, if the ventricle contraction detecting unit 3 detects the ventricular contraction before the time value of the atrioventricular delay timer 14 reaches the set value stored in the atrioventricular delay set value storage unit 15, The delay timer 14 stops counting and no ventricular stimulation is performed.
図 3は、 本発明の第 1 の実施の形態の作用を説明するためのフ ロー図である。  FIG. 3 is a flowchart for explaining the operation of the first embodiment of the present invention.
以下、 図 3のフロー図を用いて、 本例の作用を詳細に説明する。 まず、 心房刺激間隔制御部 2 8 の限界値記憶部 2 9に記憶させる 限界値を、例えば心拍数 6 0に相当する心拍間隔 1000msに設定す る。 この初期化の段階では、 心拍比較部 1 3からの出力はなく 、 限界値記憶部 2 9 に設定した 1000ms が心房刺激間隔設定部 3 3 の出力と して比較部 1 1 に供給される (ステップ S l )。  Hereinafter, the operation of the present example will be described in detail with reference to the flowchart of FIG. First, the limit value stored in the limit value storage unit 29 of the atrial stimulation interval control unit 28 is set to, for example, a heartbeat interval of 1000 ms corresponding to a heart rate of 60. At this initialization stage, there is no output from the heartbeat comparison unit 13, and 1000 ms set in the limit value storage unit 29 is supplied to the comparison unit 11 as the output of the atrial stimulation interval setting unit 33 ( Step S l).
次に、 心房刺激間隔タイマ 1 0をス ター ト させ (ステップ S 2 )、 続いて、 心房収縮検出部 5 において、 心房の収縮が検出されたか 否かが判断される (ステップ S 3 )。 判断ステップ S 3で心房収縮 が検出された場合は、 心拍計測部 9 において心拍間隔の計測、 つ ま り、 心房イベン ト間隔の計測が開始される と と もに (ステップ S 4 )、心房刺激間隔タイマ 1 0がリ セッ ト される(ステ ップ S 5 )。 次に、 心拍比較部 1 3 において、 心拍計測部 9で計測した心房 イベン ト間隔が、 心拍閾値記憶部 1 2に予め記憶された閾値、 例 えば心拍数 8 0 に相当する心拍間隔 750ms に比べて大きいか小さ いかが判断される(ステップ S 6 )。そして、心房イベン ト間隔が、 例えば 625msであり、 閾値 750ms よ り小さいと判断される と (す なわち、 心拍数が 8 0 を超える とき)、 心拍比較部 1 3から出力が 得られ、 この出力が神経刺激信号制御部 2 7に送られて迷走神経 2 6 の刺激が行われる (ステップ S 7 )。 Next, the atrial stimulation interval timer 10 is started (step S2), and subsequently, the atrial contraction detecting section 5 determines whether or not atrial contraction is detected (step S3). If an atrial contraction is detected in the determination step S3, the heartbeat measurement unit 9 starts measuring the heartbeat interval, that is, measuring the atrial event interval (step S4), and performs atrial stimulation. The interval timer 10 is reset (step S5). Next, in the heart rate comparison unit 13, the atria measured by the heart rate measurement unit 9 It is determined whether the event interval is larger or smaller than a threshold previously stored in the heartbeat threshold storage unit 12, for example, a heartbeat interval of 750 ms corresponding to a heart rate of 80 (step S6). Then, if it is determined that the atrial event interval is, for example, 625 ms and is smaller than the threshold value of 750 ms (that is, when the heart rate exceeds 80), an output is obtained from the heart rate comparing unit 13, The output is sent to the nerve stimulation signal control unit 27 to stimulate the vagus nerve 26 (step S7).
また、 心拍計測部 9で計測された心房イベン ト間隔は、 心房刺 激間隔制御部 2 8の加算部 3 1 に供給され、 ここで心房ィベン ト 間隔の計測値に增分値記憶部 3 0 に記憶されている固定の時間増 分、 例えば 100msが加算される (ステップ S 8 )。 続いて、 限界値 制限部 3 2 において、 ステップ S 8 で加算された演算値 725ms ( 625ms + 100ms ) が限界値記憶部 2 9に予め記憶されている限界 値 1000ms よ り も大きいか否かが判断される (ステップ S 9 )。 こ の場合のよ う に、 判断ステップ S 9 において、 加算部 3 1 で時間 増分が加算された演算値 725msが先に設定した限界値記憶部 2 9 に記憶されている限界値 1000ms よ り小さいときは、この新たな演 算値が限界値制限部 3 2から心房刺激間隔設定部 3 3に送られ、 心房刺激間隔設定部 3 3では、 ステップ S 6で発生した心拍比較 部 1 3の出力を得て (心房イベン ト間隔 625msが閾値 750ms よ り 小さい)、新たな演算値を心房刺激間隔タイマ 1 0 に対する閾値と して比較部 1 1 に供給する (ステップ S 1 0 )。  The atrial event interval measured by the heart rate measuring unit 9 is supplied to the adding unit 31 of the atrial stimulating interval control unit 28, where the measured value of the atrial event interval is stored in the partial value storage unit 30. A fixed time increment, for example, 100 ms, stored in the memory is added (step S8). Subsequently, in the limit value limiter 32, it is determined whether or not the calculated value 725ms (625ms + 100ms) added in step S8 is larger than the limit value 1000ms previously stored in the limit value storage unit 29. It is determined (step S9). As in this case, in the determination step S9, the calculated value 725ms to which the time increment is added by the adding unit 31 is smaller than the limit value 1000ms stored in the previously set limit value storage unit 29. At this time, the new calculated value is sent from the limit value limiting section 32 to the atrial stimulation interval setting section 33, and the atrial stimulation interval setting section 33 outputs the output of the heart rate comparing section 13 generated in step S6. (Atrial event interval 625 ms is smaller than threshold 750 ms), and a new calculated value is supplied to comparator 11 as a threshold for atrial stimulation interval timer 10 (step S 10).
判断ステップ S 6 において、 心拍計測部 9 で計測した心房ィベ ン ト間隔が、 心拍閾値記憶部 1 2に記憶されている心拍間隔閾値 750ms以上の場合 (心拍数が 8 0以下)、 及ぴ、 判断ステップ S 9 において加算部 3 1で時間増分が加算された演算値が限界値記憶 部 2 9 に記憶されている限界値 1000ms 以上の場合 (心拍間隔 900ms 以上、 すなわち心拍数が 6 6 以下) は、 引き続き限界値 1000ms を心房刺激間隔タイマ 1 0 に対する閾値と して比較部 1 1 に供給し、 次のステップへ進む (ステップ S 1 1 )。 In determination step S6, if the atrial event interval measured by the heart rate measuring unit 9 is equal to or greater than the heartbeat interval threshold 750ms stored in the heartbeat threshold storage unit 12 (heart rate is 80 or less), and If the calculated value obtained by adding the time increment by the adding unit 31 in the judgment step S 9 is equal to or greater than the limit value 1000 ms stored in the limit value storage unit 29 (heartbeat interval is 900 ms or more, that is, the heart rate is 66 or less) ) Continues to be the limit 1000ms is supplied to the comparison unit 11 as a threshold value for the atrial stimulation interval timer 10 and the process proceeds to the next step (step S11).
判断ステップ S 3 において、 心房収縮が検出されなかった場合 は、 心房刺激間隔タイマ 1 0がタイムアウ ト しているか否かが判 断される (ステップ S 1 2 )。 心房刺激間隔タイマ 1 0がタイムァ ゥ ト している場合、 すなわち、 心房刺激間隔タイマ 1 0 の計時時 間がステップ S 1 で設定された心房刺激間隔の限界値 ( 1000ms ) を超えた場合 (心拍数 6 0 ·以下) は、 比較部 1 1 から心房刺激部 4に出力が発せられて心房刺激が行われる (ステップ S 1 3 )。 ま た、 同時に、 比較部 1 1 の出力は O R回路 8 を経由して心拍計測 部 9 に供給され、 心房イベン ト間隔の計測が開始される と と もに (ステップ S 1 4 )、 心房刺激間隔タイマ 1 0 に送られ、 これをリ セッ トする (ステップ S 1 5 )。  If no atrial contraction is detected in the determination step S3, it is determined whether or not the atrial stimulation interval timer 10 has timed out (step S12). When the atrial stimulation interval timer 10 is timed out, that is, when the time measured by the atrial stimulation interval timer 10 exceeds the limit value (1000 ms) of the atrial stimulation interval set in step S 1 (heart rate) (Equation 60 · or less) is output from the comparing section 11 to the atrial stimulating section 4 to perform atrial stimulation (step S13). At the same time, the output of the comparison unit 11 is supplied to the heart rate measurement unit 9 via the OR circuit 8, and the measurement of the atrial event interval is started (step S14). It is sent to interval timer 10 and reset (step S15).
次に、 判断ステップ S 6 と同様に、 心拍計測部 9で計測した心 房イベン ト間隔が、 心拍閾.値記憶部 1 2に設定した心拍間隔閾値 750ms よ り小さいか否かが判断される (ステップ S 1 6 )。そして、 心房イベン ト間隔計測値が上記心拍閾値記憶部 1 2に記憶されて レ、る心拍間隔閾値 750ms よ り小さレ、 (心拍数 8 0超) と判断され る と、 ステップ S 8 に進み、 以下、 ステップ S 9以降の処理が実 施される。 判断ステップ S 1 6で、 心拍計測部 9で計測した心房 ィベン ト間隔計測値が、 心拍閾値記憶部 1 2に記憶されている心 拍間隔閾値 750ms以上の場合には、 心房刺激間隔は最初設定した 限界値記憶部 2 9 に記憶されている限界値 1000msのままと し(ス テツプ S 1 7 )、 次のステップに進む。  Next, similarly to the determination step S6, it is determined whether the atrial event interval measured by the heart rate measurement unit 9 is smaller than the heartbeat interval threshold value 750ms set in the heartbeat threshold value storage unit 12 or not. (Step S16). If the measured value of the atrial event interval is stored in the above-mentioned heartbeat threshold storage unit 12 and it is determined that the heartbeat interval threshold is smaller than 750 ms and the heart rate is more than 80, the process proceeds to step S 8. Hereafter, the processing after step S9 is performed. In the determination step S16, if the measured value of the atrial event interval measured by the heart rate measuring unit 9 is equal to or longer than the heartbeat interval threshold value 750ms stored in the heart rate threshold value storage unit 12, the atrial stimulation interval is initially set. The limit value stored in the limit value storage unit 29 remains 1000 ms (step S17), and the process proceeds to the next step.
心房収縮検出部 5 において心房収縮が検出されるか、 比較手段 1 1 から出力が発せられて心房刺激が行われる と、 この検出信号 または刺激信号が O R回路 8 を経て、 房室遅延タイマ 1 4に送ら れ、 房室遅延タイマ 1 4 の計時を開始させる (ステップ S 1 8 )。 そして、 次に心室収縮検出部 3 によって心室の収縮が検出された か否かが判断される (ステップ S 1 9 )。 判断ステップ S 1 9で、 心室収縮が検出される と、 房室遅延タイマ 1 4は計時を止め (ス テツプ S 2 0 )、 判断ステップ S 3 に戻る。 一方、 判断ステップ S 1 9で心室収縮が検出されないときは房室遅延タイマ 1 4がタイ ムアウ ト しているかどう力 すなわち、 房室遅延タイマ 1 4 の計 時時間が房室遅延設定値記憶部 1 5 に記憶されている設定値を超 えたか否かが判断される (ステップ S 2 1 )。 そして、 判断ステツ プ S 2 1 で房室遅延タイマ 1 4がタイムァゥ ト していないと判断 される と、 判断ステップ S 1 9 に戻り、 房室遅延タイマ 1 4がタ ィムアウ ト した場合には、 房室遅延比較部 1 6から心室刺激部 2 に出力が発せられ心室刺激が行われる (ステップ S 2 2 )。 When an atrial contraction is detected in the atrial contraction detecting section 5 or an output is issued from the comparing means 11 and an atrial stimulation is performed, the detected signal or the stimulating signal passes through the OR circuit 8 and the atrioventricular delay timer 14 To start the time measurement of the atrioventricular delay timer 14 (step S18). Then, it is determined whether or not the ventricle contraction is detected by the ventricle contraction detection unit 3 (step S19). If a ventricular contraction is detected in the decision step S19, the atrioventricular delay timer 14 stops counting (step S20) and returns to the decision step S3. On the other hand, if ventricular contraction is not detected in decision step S 19, whether the atrioventricular delay timer 14 has timed out, that is, the time measured by the atrioventricular delay timer 14, the atrioventricular delay set value storage unit It is determined whether the set value stored in 15 has been exceeded (step S21). Then, when it is determined in the determination step S21 that the atrioventricular delay timer 14 has not timed out, the flow returns to the determination step S19, and when the atrioventricular delay timer 14 has timed out, An output is output from the atrioventricular delay comparing section 16 to the ventricular stimulating section 2 to perform ventricular stimulation (step S22).
次に、 図 4のブロ ック構成図に基づいて、 本発明の心臓治療装 置の第 2の実施形態を説明する。 図 1 に示す本発明の第 1 の実施 形態と同一部分については、 同一符号を付す。 第 1 の実施形態で は、 心房収縮の検出に基づいて迷走神経 2 6 の刺激を制御する と と もに、 心房刺激間隔を制御するものであるが、 第 2の実施形態 では心室収縮の検出によって心拍間隔を計測し、 迷走神経 2 6の 刺激及び心室刺激間隔を制御しょ う とするものである。  Next, a second embodiment of the heart treatment apparatus of the present invention will be described based on the block diagram of FIG. The same parts as those in the first embodiment of the present invention shown in FIG. 1 are denoted by the same reference numerals. In the first embodiment, the stimulation of the vagus nerve 26 is controlled based on the detection of atrial contraction, and the atrial stimulation interval is controlled.In the second embodiment, the detection of ventricular contraction is performed. The heartbeat interval is measured to control the vagus nerve 26 stimulation and the ventricular stimulation interval.
すなわち、 本発明の第 2の実施形態が第 1 の実施形態と構成上 異なる ところは、'比較部 1 1 の出力が心室刺激部 2に供給され、 心室収縮検出部 3 の出力が O R回路 8及び神経刺激信号制御部 2 7に供給されている点、 及び第 1 の実施形態の心房刺激間隔制御 部 2 8 と心房刺激間隔設定部 3 3 の代わり に心室刺激間隔制御部 2 8 Aと心室刺激間隔設定部 3 3 Aが設けられている点である。 その結果、 図 1 に示す本発明の第 1 の実施形態における、 心房 刺激部 4、 心房収縮検出部 5、 房室遅延タイマ 1 4、 房室遅延設 定値記憶部 1 5、 房室遅延比較部 1 6 は、 第 2の実施形態からは 削除されている。 That is, the second embodiment of the present invention is different from the first embodiment in configuration in that the output of the comparison unit 11 is supplied to the ventricle stimulating unit 2 and the output of the ventricular contraction detecting unit 3 is OR circuit 8 And a point supplied to the nerve stimulation signal control unit 27, and a ventricle stimulation interval control unit 28A and a ventricle instead of the atrial stimulation interval control unit 28 and the atrial stimulation interval setting unit 33 in the first embodiment. The point is that a stimulus interval setting section 33 A is provided. As a result, in the first embodiment of the present invention shown in FIG. 1, the atrial stimulating unit 4, the atrial contraction detecting unit 5, the atrioventricular delay timer 14, the atrioventricular delay setting value storage unit 15, the atrioventricular delay comparing unit 16 is from the second embodiment Has been deleted.
本発明の心臓治療装置の第 2の実施形態の動作を、 図 5 に示す フロー図によ り説明する。  The operation of the second embodiment of the heart treatment apparatus of the present invention will be described with reference to the flowchart shown in FIG.
まず、 心室刺激間隔制御部 2 8 Aの限界値記憶部 2 9 に記憶さ せる限界値を、例えば心拍数 6 0 に相当する心拍間隔 1000ms に設 定する。 この初期化の段階では、 心拍比較部 1 3からの出力はな く 、限界値記憶部 2 9に設定した 1000msが心室刺激間隔設定部 3 3 Aの出力と して比較部 1 1 に供給される (ステップ S 3 1 )。 次 に、心室刺激間隔タイマ 1 0 Aをス ター ト させ(ステップ S 3 2 )、 続いて、 心室収縮検出部 3 において、 心室の収縮が検出されたか 否かが判断される (ステップ S 3 3 )。 判断ステップ S 3 3で心室 収縮が検出された場合は、心拍計測部 9 において心拍間隔の計測、 すなわち心室イベン ト間隔の計測が開始されると と もに (ステツ プ S 3 4 )、 心室刺激間隔タイマ 1 0 Aがリセッ ト される (ステツ プ S 3 5 )。  First, the limit value to be stored in the limit value storage unit 29 of the ventricular stimulation interval control unit 28A is set to, for example, a heartbeat interval 1000 ms corresponding to a heart rate 60. At this initialization stage, there is no output from the heart rate comparison unit 13, and 1000 ms set in the limit value storage unit 29 is supplied to the comparison unit 11 as the output of the ventricular stimulation interval setting unit 33 A. (Step S31). Next, the ventricular stimulation interval timer 10A is started (step S32), and subsequently, the ventricular contraction detector 3 determines whether or not ventricle contraction is detected (step S33). ). If a ventricular contraction is detected in the determination step S33, the heartbeat measuring unit 9 starts measuring the heartbeat interval, that is, measuring the ventricular event interval (step S34), and performs the ventricular stimulation. The interval timer 10A is reset (step S35).
次に、 心拍計測部 9で計測した心室イベン ト間隔 (心拍間隔) が、 心拍閾値記憶部 1 2に設定した心拍間隔閾値 750ms に達した か否かが判断される (ステップ S 3 6 )。 そして、 心室イベン ト間 隔が上記閾値 750ms よ り小さい (心拍数が 8 0以上) と判断され る と、 心拍比較部 1 3から出力が得られ、 この出力が神経刺激信 号制御部 2 7に送られて迷走神経 2 6 の刺激が為される (ステツ プ S 3 7 )。  Next, it is determined whether or not the ventricular event interval (heartbeat interval) measured by the heartbeat measurement unit 9 has reached the heartbeat interval threshold 750 ms set in the heartbeat threshold storage unit 12 (step S36). When it is determined that the ventricular event interval is smaller than the threshold value 750 ms (heart rate is 80 or more), an output is obtained from the heart rate comparison unit 13, and this output is output to the nerve stimulation signal control unit 27. And the vagus nerve 26 is stimulated (step S37).
また、 心拍計測部 9で計測された心室イベン ト間隔は、 心室刺 激間隔制御部 2 8 Aの加算部 3 1 に供給され、 この心室イベン ト 間隔の計測値に増分値記憶部 3 0に記憶されている固定の時間增 分 100msが加算される (ステップ S 3 8 )。 そして、 限界値制限部 3 2 において、 ステップ S 3 8で加算された演算値が限界値記憶 部 2 9 に予め記憶されている限界値 1000ms よ り も小さいか否か W The ventricular event interval measured by the heart rate measurement unit 9 is supplied to the addition unit 31 of the ventricular stimulation interval control unit 28A, and the measured value of the ventricular event interval is stored in the increment value storage unit 30. The stored fixed time 100 minutes is added (step S38). Then, in the limit value limiting section 32, it is determined whether or not the calculated value added in step S38 is smaller than the limit value 1000ms stored in advance in the limit value storing section 29. W
が判断される (ステップ S 3 9 )。 判断ステップ S 3 9 において、 加算部 3 1で時間增分が加算された演算値が先に設定した限界値 記憶部 2 9 に記憶されている限界値 1000ms よ り小さいと判断さ れた場合は、 この新たな演算値が限界値制限部 3 2から心室刺激 間隔設定部 3 3 Aに送られ、 心室刺激間隔設定部 3 3 Aではステ ップ S 3 6で発生した心拍比較部 1 3 の出力を得て (心室ィベン ト間隔が心拍間隔閾値よ り小さい)、新たな演算値が心室刺激間隔 タイマ 1 O Aに対する閾値と して比較部 1 1 に供給される (ステ ップ S 4 0 )。 ' Is determined (step S39). In the judgment step S39, if it is judged that the calculated value obtained by adding the time and the minute by the adding unit 31 is smaller than the limit value 1000ms stored in the previously set limit value storage unit 29, The new calculated value is sent from the limit value limiting unit 32 to the ventricular stimulation interval setting unit 33A, and the ventricular stimulation interval setting unit 33A outputs the heart rate comparison unit 13 generated in step S36. The output is obtained (the ventricular event interval is smaller than the heartbeat interval threshold), and the new calculated value is supplied to the comparison unit 11 as a threshold for the ventricular stimulation interval timer 1 OA (step S40). . '
判断ステップ S 3 6において、 心拍計測部 9で計測した心室ィ ベン ト間隔が、 心拍閾値記憶部 1 2 に記憶されている心拍間隔闘 値 750ms よ り大きい場合 (心拍数が 8 0以下)、 及ぴ、 判断ステツ プ S 3 9 において加算部 3 1 で時間増分が加算された演算値が限 界値記憶部 2 9 に記憶されている限界値 1000ms よ り大きい場合 (心拍間隔 900ms以上、 すなわち心拍数が 6 6以下) は、 引き続 き限界値 1000ms を心室刺激間隔タイマ 1 0 Aに対する閾値と し て比較部 1 1 に供給し、 次のステップへ進む (ステップ S 4 1 )。  In the determination step S36, if the ventricular event interval measured by the heart rate measurement unit 9 is larger than the heartbeat interval threshold value 750ms stored in the heart rate threshold storage unit 12 (heart rate is 80 or less), In addition, when the calculated value obtained by adding the time increment in the adding unit 31 in the judgment step S39 is larger than the limit value 1000ms stored in the limit value storing unit 29 (heartbeat interval 900ms or more, that is, If the heart rate is 66 or less, the limit value 1000 ms is continuously supplied to the comparison unit 11 as a threshold value for the ventricular stimulation interval timer 10 A, and the process proceeds to the next step (step S 41).
判断ステップ S 3 3において、 心室収縮が検出されなかった場 合は、 心室刺激間隔タイマ 1 0 Aがタイムァゥ ト しているか否か が判断される (ステップ S 4 2 )。 心室刺激間隔タイマ 1 0 Aがタ ィムアウ ト している場合、 すなわち、 心室刺激間隔タイマ 1 0 A の計時時間がステップ S 3 1 で設定された心室刺激間隔の限界値 1000ms を超えた場合は、 比較部 1 1 力 ら心室刺激部 2に出力が発 せられて心室刺激が為される (ステップ S 4 3 )。 また、 同時に、 比較部 1 1 の出力は O R回路 8 を経由して心拍計測部 9に供給さ れ、 心室イベン ト間隔の計測が開始されると と もに (ステップ S 4 4 )、 心室刺激間隔タイマ 1 O Aに送られ、 これをリセッ トする (ステップ S 4 5 )。 次に、 判断ステップ S 3 6 と同様に、 心拍計測部 9で計測した 心室ィベン ト間隔が、 心拍閾値記憶部 1 2に設定した心拍間隔閾 値 750ms よ り小さいか否かが判断される (ステップ S 4 6 )。 そし て、 計測した心室イベン ト間隔が上記心拍閾値記憶部 1 2 に記憶 されている心拍間隔閾値 750ms よ り小さいと判断されると、 ステ ップ S 3 8 に進み、 以下、 ステップ S 3 9以降の処理が実施され る。 判断ステップ S 4 6で、 心拍計測部 9で計測した心房ィベン ト間隔が心拍閾値記憶部 1 2 に記憶されている心拍間隔閾値 750ms よ り大きいと判断される と、 心室刺激間隔は最初に設定し た限界値記憶部 2 9 に記憶されている限界値(1000ms)のままと し て比較部 1 1 に供給し(ステップ S 4 7 )、ステップ S 3 3 に戻る。 If no ventricular contraction is detected in determination step S33, it is determined whether ventricular stimulation interval timer 10A has timed out (step S42). If the ventricular stimulation interval timer 10A has timed out, that is, if the time measured by the ventricular stimulation interval timer 10A exceeds the limit value 1000ms of the ventricular stimulation interval set in step S31, An output is output from the comparator 11 to the ventricular stimulator 2 to perform ventricular stimulation (step S43). At the same time, the output of the comparison unit 11 is supplied to the heart rate measurement unit 9 via the OR circuit 8, and the measurement of the ventricular event interval is started (step S44). It is sent to the interval timer 1 OA and reset (step S45). Next, similarly to the determination step S36, it is determined whether or not the ventricular event interval measured by the heart rate measuring unit 9 is smaller than the heartbeat interval threshold value 750ms set in the heartbeat threshold value storage unit 12 ( Step S4 6). If it is determined that the measured ventricular event interval is smaller than the heartbeat interval threshold value 750 ms stored in the heartbeat threshold value storage unit 12, the process proceeds to step S 38, and thereafter, proceeds to step S 39. The following processing is performed. In determination step S46, if it is determined that the atrial event interval measured by the heart rate measurement unit 9 is larger than the heartbeat interval threshold 750ms stored in the heart rate threshold storage unit 12, the ventricular stimulation interval is set first. The limit value (1000 ms) stored in the stored limit value storage unit 29 is supplied to the comparison unit 11 (step S47), and the process returns to step S33.
図 6は、 図 4に示す本発明の第 2の実施形態において、 迷走神 経の刺激と心室刺激間隔の関係を示すタイ ミ ングチャー トであり 心室刺激間隔限界値 1000ms、心拍間隔閾値 750ms、時間増分 100ms と して心室刺激と迷走神経刺激を制御する例を示したものである ( 心室刺激の代わり に心房刺激とすれば、 図 1 に示す本発明の第 1 の実施形態にも適用できることは言う までもない。 FIG. 6 is a timing chart showing the relationship between the vagus nerve stimulation and the ventricular stimulation interval in the second embodiment of the present invention shown in FIG. 4, the ventricular stimulation interval limit value 1000 ms, the heartbeat interval threshold value 750 ms, and the time. An example is shown in which ventricular stimulation and vagal stimulation are controlled in increments of 100 ms. ( If atrial stimulation is used instead of ventricular stimulation, it can be applied to the first embodiment of the present invention shown in FIG. 1. Needless to say.
この図 6のタイ ミ ングチヤ一トにおいて、 時間 VI , V2, V3, V4, V5 は心室刺激が行われた時点を表し、 時間 Rl , R2は心室収縮が検出 された時点を表している。  In the timing chart of FIG. 6, times VI, V2, V3, V4, and V5 represent times when ventricular stimulation is performed, and times R1 and R2 represent times when ventricular contraction is detected.
すなわち、 時間 V I において、 心室刺激部 2からの心室刺激と と もに、 心室刺激間隔タイマ 1 0 Aをス ター ト させる。 心室刺激 間隔の限界値 1000msの間に、 心室収縮が検出されなかったため、 心室刺激間隔タイマ 1 0 Aがタイムアウ ト した (限界値 1000ms) と判断され、 時間 V2で心室刺激が行われることを示している。 続いて、 時間 V2 で心室刺激が為されてから 850ms後の時間 R1 において、 心室の収縮が検出され、 その結果心室刺激間隔タイマ 1 0 Aがリセッ ト される。 このとき心拍計測部 9で計測した心室 イベン ト間隔は 850msであり、 心拍間隔閾値 750ms よ り大き く 、 心拍比較部 1 3 よ り神経刺激信号制御部 2 7に出力が発せられな いので、 迷走神経 2 6 の刺激は行われない。 また、 加算部 3 1 に は心拍計測部 9から 850ras という値が供給され、 この値と増分値 記憶部 3 0の固定の時間増分 100msが加算される。 この加算され た演算値 950msが限界値制限部 3 2に送られ、 ここで限界値記憶 部 2 9 に記憶されている限界値 1000ms と比較される。 演算値 950ms は限界値 1000ms'よ り小さレヽので、 限界値制限部 3 2力 らは 演算値 950 msが心室刺激間隔設定部 3 3 Aに供給される。 一方、 心室刺激間隔設定部 3 3 Aには、 心拍比較部 1 3からの出力が供 給されているが、 心拍計測部 9で計測された心室イベン ト間隔が 850ms で心拍間隔閾値の 750ms よ り大きいため、 心拍比較部 1 3 からは出力が得られない。 心拍比較部 1 3からの出力がない状態 では、 心室刺激間隔設定部 3 3 Aは限界値記憶部 2 9 の限界値 1000ms を選択し、 この値が心室刺激間隔の閾値と して比較部 1 1 に送られる。 That is, at time VI, the ventricular stimulation interval timer 10 A is started together with the ventricular stimulation from the ventricular stimulating unit 2. Since no ventricular contraction was detected during the threshold value of the ventricular stimulation interval of 1000 ms, the ventricular stimulation interval timer 10A was determined to have timed out (limit value of 1000 ms), indicating that ventricular stimulation was performed at time V2. ing. Subsequently, at time R1, 850 ms after the ventricular stimulation is performed at time V2, the contraction of the ventricle is detected, and as a result, the ventricular stimulation interval timer 10A is reset. The ventricle measured by the heart rate measurement unit 9 at this time The event interval is 850 ms, which is larger than the heartbeat interval threshold 750 ms, and the vagus nerve 26 is not stimulated because no output is sent to the nerve stimulation signal control unit 27 from the heartbeat comparison unit 13. . The value of 850 ras is supplied to the adding unit 31 from the heart rate measuring unit 9, and this value is added to the fixed time increment 100 ms of the increment value storing unit 30. The added calculated value 950 ms is sent to the limit value limiting section 32, where it is compared with the limit value 1000 ms stored in the limit value storing section 29. Since the calculated value 950 ms is smaller than the limit value 1000 ms', the calculated value 950 ms is supplied to the ventricular stimulation interval setting unit 33 A from the limit value limiting unit 32. On the other hand, although the output from the heart rate comparing section 13 is supplied to the ventricular stimulation interval setting section 33 A, the ventricular event interval measured by the heart rate measuring section 9 is 850 ms, and the heartbeat interval threshold value is 750 ms. Therefore, no output is obtained from the heart rate comparison unit 13. When there is no output from the heart rate comparison unit 13, the ventricular stimulation interval setting unit 33 A selects the limit value 1000 ms of the limit value storage unit 29, and this value is used as the threshold value of the ventricular stimulation interval by the comparison unit 1. Sent to 1.
次に、 心拍数が早く なつて、 時間 R 1 で心室の検出が為されて から 625ms後の時間 R2において、再ぴ心室の収縮が検出される と する。 この時間 R2での心室の検出によ り、 心室刺激間隔タイマ 1 0 Aはリセッ ト される。 この場合は、 計測した心室イベン ト間隔 が 625msで心拍間隔閾値 750msを下回っているので、 心拍比較部 1 3 よ り神経刺激信号制御部 2 7 に信号が送られ、 神経刺激部 6 によって迷走神経 2 6 の刺激が行われる。 そして、 同時に加算部 3 1 において、 心拍計測部 9からの心室イベン ト間隔 625ms に増 分値記憶部 3 0に記憶されている時間増分 100msが加算され、 こ の演算値 725msが限界値制限部 3 2に送られる。 限界値制限部 3 2において、 限界値記憶部 2 9 に記憶されている限界値 1000ms と比較され、 演算値が限界値よ り小さいので限界値制限部 3 2は この演算値 725ms を次の心室刺激間隔の候補と して心室刺激間隔 設定部 3 3 Aに送る。 このとき、 心室イベン ト間隔は 625msであ り心拍閾値記憶部 1 2 に記憶されている心拍間隔閾値 750ms よ り 小さいので、 心拍比較部 1 3からの出力が心室刺激間隔設定部 3 3 Aに加えられている。 したがって、 心室刺激間隔設定部 3 3 A では、 演算値 725msが選択されて出力され、 新たな心室刺激間隔 の閾値と して比較部 1 1 に送られる。 Next, it is assumed that the heart rate is increased, and the contraction of the regenerated ventricle is detected at time R2 625 ms after the detection of the ventricle at time R1. By detecting the ventricle at this time R2, the ventricular stimulation interval timer 10A is reset. In this case, since the measured ventricular event interval is 625 ms, which is smaller than the heartbeat interval threshold 750 ms, a signal is sent from the heartbeat comparison unit 13 to the nerve stimulation signal control unit 27, and the nerve stimulation unit 6 sends the signal to the vagus nerve. 26 stimulations are performed. At the same time, the addition unit 31 adds the time increment 100 ms stored in the increment value storage unit 30 to the ventricular event interval 625 ms from the heart rate measurement unit 9, and the calculated value 725 ms is used as the limit value limiting unit. Sent to 3 2 In the limit value limiter 3 2, the limit value limiter 3 2 is compared with the limit value 1000 ms stored in the limit value storage unit 29 and the calculated value is smaller than the limit value. The calculated value 725 ms is sent to the ventricular stimulation interval setting unit 33 A as a candidate for the next ventricular stimulation interval. At this time, since the ventricular event interval is 625 ms, which is smaller than the heartbeat interval threshold 750 ms stored in the heartbeat threshold storage unit 12, the output from the heartbeat comparison unit 13 is sent to the ventricular stimulation interval setting unit 33 A. Have been added. Therefore, the ventricular stimulation interval setting unit 33A selects and outputs the calculated value 725ms, and sends it to the comparison unit 11 as a new threshold value of the ventricular stimulation interval.
次に、 上記新たに設定した心室刺激間隔の閾値 725ms の間に心 室収縮が検出されないと、 心室刺激間隔タイマ 1 0 Aがタイムァ ゥ ト したと判定され、 時間 R2から 725ms後の時間 V3で心室刺激 が行われる と と もに、 心室刺激間隔タイマ 1 0 Aがリセッ ト され る。 このと き、 計測した心室イベン ト間隔が 725msで心拍閾値記 憶部 1 2に記憶されている心拍間隔閾値 750ms を下回っているの で、 心拍比較部 1 3から出力が神経刺激信号制御部 2 7に供給さ れているが、 心室収縮検出部 3 において心室の収縮が検出されな いため、 迷走神経 2 6 の刺激は起こ らない。 心拍計測部 9 の計測 値 725msは加算部 3 1 に供給され、 加算部 3 1 において、 増分値 記憶部 3 0に記憶されている時間增分 100msが加算されて、 加算 された演算値 825msが心室刺激間隔の候補と して限界値制限部 3 2を経て心室刺激間隔設定部 3 3 Aに送られる。 このとき心室刺 激間隔設定部 3 3 Aには心拍比較部 1 3 の出力が加えられている ので心室刺激間隔設定部 3 3 Aの出力は演算値 825ms となり、 こ の値が新たな心室刺激間隔の閾値と して比較手段 1 1 に供給され る。  Next, if no ventricular contraction is detected during the newly set ventricular stimulation interval threshold value of 725 ms, it is determined that the ventricular stimulation interval timer 10A has timed out, and at time V3, which is 725 ms after time R2. As the ventricular stimulation is performed, the ventricular stimulation interval timer 10A is reset. At this time, the measured ventricular event interval is 725 ms, which is lower than the heartbeat interval threshold 750 ms stored in the heartbeat threshold storage unit 12, so the output from the heartbeat comparison unit 13 is the neural stimulation signal control unit 2. 7, but no stimulation of the vagus nerve 26 occurs because no ventricular contraction is detected by the ventricular contraction detector 3. The measured value 725 ms of the heart rate measuring unit 9 is supplied to the adding unit 31, and the adding unit 31 adds the time / minute 100 ms stored in the increment value storing unit 30 to obtain the calculated value 825 ms. It is sent to the ventricular stimulation interval setting unit 33 A via the limit value limiting unit 32 as a candidate for the ventricular stimulation interval. At this time, since the output of the heart rate comparison unit 13 is added to the ventricular stimulation interval setting unit 33 A, the output of the ventricular stimulation interval setting unit 33 A is a calculated value of 825 ms, and this value is a new ventricular stimulation. It is supplied to the comparison means 11 as the interval threshold.
そして、 新たな心室刺激間隔 825ms の間に心室収縮が検出され ないと、 心室刺激間隔タイマ 1 0 Aがタイムアウ ト したと判定さ れ、 時間 V3から 825ms後の時間 V4で心室刺激が行われる と と も に、 心室刺激間隔タイマ 1 0 Aがリセッ ト される。 このとき心拍 計測部 9 で計測した心室イベン ト間隔 825ms が心拍間隔閾値 750ms よ り も大き く なるので、 心拍比較部 1 3からの出力はなく 迷走神経 2 6 の刺激は行われない。 加算部 3 1 において、 上記心 室ィベン ト間隔 825ms と固定の時間増分 100msが加算され、 新た な演算値 925msが限界値制限部 3 2から心室刺激間隔設定部 3 3 Aに送られるが、 心室刺激間隔設定部 3 3 Aには心拍比較部 1 3 からの出力が与えられていないので心室刺激間隔設定部 3 3 Aは 限界値記憶部 2 9 に記憶されている限界値 1000ms を選択し、比較 部 1 1 に送る。 すなわち、 心室刺激間隔の閾値は限界値 1000ms に戻るこ とになる。 時間 V4から時間 V5に至る 1000msの間で、 心 室収縮の検出がないと、 心室刺激間隔タイマ 1 0 Aがタイムァゥ トすると と もに心室刺激が行われる。 If no ventricular contraction is detected during the new ventricular stimulation interval 825 ms, it is determined that the ventricular stimulation interval timer 10 A has timed out, and the ventricular stimulation is performed at time V4 825 ms after time V3. At the same time, the ventricular stimulation interval timer 10A is reset. Heartbeat at this time Since the ventricular event interval 825 ms measured by the measurement unit 9 is larger than the heartbeat interval threshold 750 ms, there is no output from the heartbeat comparison unit 13 and the vagus nerve 26 is not stimulated. The adder 31 adds the above-mentioned ventricular event interval of 825 ms and a fixed time increment of 100 ms, and sends a new calculated value of 925 ms from the limit value limiter 32 to the ventricular stimulation interval setting unit 33 A. Since the output from the heartbeat comparison unit 13 is not given to the stimulation interval setting unit 33A, the ventricular stimulation interval setting unit 33A selects the limit value 1000ms stored in the limit value storage unit 29, Send to comparison part 1 1. That is, the threshold of the ventricular stimulation interval returns to the limit value of 1000 ms. If no ventricular contraction is detected during 1000 ms from time V4 to time V5, the ventricular stimulation interval timer 10A times out and ventricular stimulation is performed.
図 7は、 図 1及び図 4 に示す本発明の第 1 の実施形態及び第 2 の実施形態における、 心房刺激間隔制御部 2 8及び心室刺激間隔 制御部 2 8 Aの第 1 の変形例を示すブロ ック構成図である。 この 変形例は時間増分が心拍間隔の所定割合と したときの心房 Z心室 刺激間隔制御部 ( 2 8, 2 8 A ) を示すものである。  FIG. 7 shows a first modification of the atrial stimulation interval control unit 28 and the ventricular stimulation interval control unit 28A in the first embodiment and the second embodiment of the present invention shown in FIGS. 1 and 4. FIG. This modification shows the atrial Z ventricular stimulus interval control unit (28, 28A) when the time increment is a predetermined ratio of the heartbeat interval.
本変形例では、 図 1及び図 4の増分値記憶部 3 0 に代えて、 増 分割合記憶部 3 4 と増分値算出部 3 5が設けられている。  In this modified example, an increment ratio storage section 34 and an increment value calculation section 35 are provided instead of the increment value storage section 30 in FIGS.
以下、 この図 7に示す第 1 の変形例の心房 心室刺激間隔制御 部 ( 2 8、 2 8 A ) の作用を説明する。 增分割合記憶部 3 4 には、 例えば 2 0 %の増分割合が設定されており、 例えば心拍計測部 9 によって計測された心房あるいは心室のイベン ト間隔が 600msで あるとすると、 増分値算出部 3 5 において、 心拍計測部 9からの 600ms という値に 2 0 %を乗算した 120ms という時間増分が算出 される。 そして、 加算部 3 1 において心拍計測部 9からの 600ms という値と増分値算出部 3 5からの 120ms という値が加算され、 限界値制限部 3 2 に 720ms という値が出力される。 限界値制御部 3 2 はこの 720ms という値と限界値記憶部 2 9 に予め記憶されて いる固定値 1000ms とを比較する。この場合は、新たな演算値 720ms とレヽ ぅ値は、 限界値 1000ms よ り小さいので、 この新たな演算値が 限界値制御部 3 2から出力され、心房 心室刺激間隔設定部 3 3、 3 3 Aに送られる。 このとき心拍比較部 1 3からの出力があるた め、 心房/心室刺激間隔制御部 3 3、 3 3 Aはこの新たな演算値 720ms を選択し、 これを心房または心室刺激間隔の新たな閾値と して比較部 1 1 に供給する。 Hereinafter, the operation of the atrial / ventricular stimulation interval control section (28, 28A) of the first modified example shown in FIG. 7 will be described. For example, an increment rate of 20% is set in the segment ratio storage section 34. For example, if the event interval of the atrium or ventricle measured by the heart rate measuring section 9 is 600 ms, the increment value calculating section At 35, a time increment of 120ms is calculated by multiplying the value of 600ms from the heart rate measurement unit 9 by 20%. Then, the value of 600 ms from the heart rate measurement unit 9 and the value of 120 ms from the increment value calculation unit 35 are added in the addition unit 31, and a value of 720 ms is output to the limit value restriction unit 32. Limit value control section 32 compares the value of 720 ms with a fixed value of 1000 ms stored in advance in the limit value storage unit 29. In this case, the new calculated value is 720 ms and the threshold value is smaller than the limit value of 1000 ms, so the new calculated value is output from the limit value control unit 32 and the atrial / ventricular stimulation interval setting units 3 3 and 3 3 Sent to A. At this time, since there is an output from the heart rate comparison unit 13, the atrial / ventricular stimulation interval control units 33, 33 A select this new calculated value 720 ms and set it to the new threshold value of the atrial or ventricular stimulation interval. This is supplied to the comparison unit 11.
図 8は、 図 7 と同様に、 図 1及び図 4に示す本発明の第 1 の実 施形態及び第 2の実施形態における、 心房刺激間隔制御部 2 8及 び心室刺激間隔制御部 2 8 Aの第 2の変形例を示すプロ ック構成 図である。 この変形例は時間増分が固定した心拍数低下に相当す る時間間隔と したときの心房 Z心室刺激間隔制御部 ( 2 8, 2 8 A ) を示すものである。  FIG. 8, like FIG. 7, shows the atrial stimulation interval control unit 28 and the ventricular stimulation interval control unit 28 in the first embodiment and the second embodiment of the present invention shown in FIG. 1 and FIG. FIG. 11 is a block diagram showing a second modification of A. This modification shows the atrial Z ventricular stimulation interval controller (28, 28A) when the time increment is a time interval corresponding to a fixed decrease in heart rate.
本変形例によれば、 心拍計測部 9からの心拍間隔 (心房ィベン ト間隔または心室イベン ト間隔) が供給される心拍数変換部 3 6 と、 例えば 1分間に 2 0拍の心拍数低下が設定される心拍数低下 分記憶部 3 7 と、 心拍数変換部 3 6 の出力から心拍数低下分記憶 部 3 7 の設定値 2 0拍を減算する減算部 3 8 と、 減算部 3 8 の出 力を心拍間隔に変換する心拍間隔変換部 3 9が設けられる。  According to this modification, the heart rate conversion unit 36 to which the heart rate interval (atrial event interval or ventricular event interval) is supplied from the heart rate measurement unit 9 and a heart rate decrease of, for example, 20 beats per minute are provided. The set value of the reduced heart rate storage unit 37 is subtracted from the output of the heart rate conversion unit 36, and the subtraction unit 38 and the subtraction unit 3 8 A heartbeat interval conversion unit 39 for converting the output into a heartbeat interval is provided.
以下、 図 8 に示す心房/心室刺激間隔制御部 ( 2 8、 2 8 A ) の作用を説明する。 心拍数低下分記憶部 3 7 には、 毎分 2 0拍の 心拍数低下が設定されている。 そして、 心拍計測部 9 によって計 測された心房あるいは心室のィベン ト間隔が 600msであったとす る と、 この値が心拍数変換部 3 6に供給され、 毎分の心拍数 1 0 0 ( 60 s/ 600ms) に変換される。 その後、 減算部 3 8 によ り、 心 拍数変換部 3 6の出力である心拍数 1 0 0から心拍数低下分記憶 部 3 7に記憶されている心拍数低下分 2 0が減算され、 心拍数 8 0 という値が減算部 3 8から心拍間隔変換部 3 9 に供給される。 心拍間隔変換部 3 9 は、 心拍数 8 0 を心拍間隔 750ms に変換し、 この値を限界値制限部 3 2に供給する。 The operation of the atrial / ventricular stimulation interval controller (28, 28A) shown in FIG. 8 will be described below. In the heart rate decrease storage section 37, a heart rate decrease of 20 beats per minute is set. If the event interval of the atrium or ventricle measured by the heart rate measurement unit 9 is 600 ms, this value is supplied to the heart rate conversion unit 36, and the heart rate per minute 100 (60) s / 600ms). Thereafter, the subtraction unit 38 subtracts the heart rate decrease 20 stored in the heart rate decrease storage unit 37 from the heart rate 100 output from the heart rate conversion unit 36, Heart rate 8 A value of 0 is supplied from the subtraction unit 38 to the heartbeat interval conversion unit 39. The heartbeat interval converter 39 converts the heart rate 80 into a heartbeat interval of 750 ms, and supplies this value to the limit value limiter 32.
そして、 限界値制限部 3 2において、 この心拍間隔変換部 3 9 の出力である 750ms という値が、 限界値記憶部 2 9 に記憶されて いる限界値 1000ms と比較される。この新たな演算値 750msは限界 値記憶部 2 9の限界値 1000ms よ り小さいので、限界値制限部 3 2 は新たな演算値 750ms を心房 Z心室刺激間隔設定部 3 3、 3 3 A に送る。 このとき、 心房/心室刺激間隔設定部 3 3、 3 3 Aは、 心拍比較部 1 3からの出力があるので、 新たな演算値 750ms を新 しい心房または心室刺激間隔の閾値と して比較部 1 1 に供給する, 以上、 本発明の第 1及び第 2の実施形態とその変形例について 説明したが、 本発明は上記実施の形態にと らわれるこ となく 、 特 許請求の範囲の記載を逸脱しない範囲で幅広い実施の形態をとる こ とが可能である。  Then, the limit value limiting section 32 compares the value of 750 ms output from the heartbeat interval converting section 39 with the limit value 1000 ms stored in the limit value storing section 29. Since this new calculated value 750 ms is smaller than the limit value 1000 ms of the limit value storage unit 29, the limit value limiting unit 32 sends the new calculated value 750 ms to the atrial Z ventricular stimulation interval setting units 33, 33A. . At this time, the atrial / ventricular stimulation interval setting unit 33, 33A receives the output from the heart rate comparison unit 13 and uses the new calculated value 750 ms as the threshold value for the new atrial or ventricular stimulation interval. As described above, the first and second embodiments of the present invention and their modifications have been described. However, the present invention is not limited to the above-described embodiments, and is described in the claims. A wide range of embodiments can be adopted without departing from the scope of the present invention.
以上述べたよ う に、 本発明によれば、 迷走神経刺激後の心拍数 変化を所定範囲内となるよ う に心臓の刺激間隔を調節するこ とが できるので、 迷走神経刺激にと もなう心拍数の急激な変化を防止 するこ とができる と と もに、 これによ り心拍数の急激な変化によ る致死的不整脈の発生を抑えるこ とができる。  As described above, according to the present invention, the heart stimulation interval can be adjusted so that the heart rate change after the vagus nerve stimulation falls within a predetermined range, so that the present invention is also used for vagal nerve stimulation. A rapid change in heart rate can be prevented, and a fatal arrhythmia caused by a rapid change in heart rate can be suppressed.

Claims

請求の範囲 The scope of the claims
1 . 迷走神経を刺激する神経刺激手段と、  1. Nerve stimulation means for stimulating the vagus nerve;
心臓の自己収縮を検出する心臓収縮検出手段と、  Heart contraction detection means for detecting the self-contraction of the heart,
前記自 己収縮に関する検出結果から心臓の拍動を計測する心 拍計測手段と、  Heartbeat measuring means for measuring the heartbeat from the detection result regarding the self-contraction,
予め定めた期間内に前記心臓の自 己収縮が検出されなかった 場合に心臓を刺激する心臓刺激手段と、  Heart stimulating means for stimulating the heart if no self-contraction of the heart is detected within a predetermined period;
前記心臓の拍動を計測した心拍出力 と予め定めた心拍閾値を 比較す'る心拍比較手段と、  Heart rate comparing means for comparing a heart rate output obtained by measuring the heart beat with a predetermined heart rate threshold;
前記心拍比較手段の出力に基づいて迷走神経刺激を行う か否 かを決定し、 迷走神経刺激を行った場合に、 前記予め定めた期間 を前記計測した心拍出力に基づいて変更するよ う制御するこ とを 特徴とする心臓治療装置。  It is determined whether or not to perform vagal nerve stimulation based on the output of the heartbeat comparison means, and when the vagus nerve stimulation is performed, control is performed such that the predetermined period is changed based on the measured heartbeat output. A heart treatment device characterized by this.
2 . 前記計測した心拍出力が心拍間隔であることを特徴とする請 求の範囲第 1項に記載の心臓治療装置。  2. The heart treatment device according to claim 1, wherein the measured heartbeat output is a heartbeat interval.
3 . 前記予め定めた期間を変更する制御が、 前記計測した心拍間 隔に予め定めた時間増分を加えるものである請求の範囲第 2項に 記載の心臓治療装置。  3. The heart treatment apparatus according to claim 2, wherein the control for changing the predetermined period is to add a predetermined time increment to the measured heartbeat interval.
4 . 前記予め定めた時間増分が固定した時間間隔である請求の範 囲第 3項に記載の心臓治療装置。  4. The heart treatment device according to claim 3, wherein the predetermined time increment is a fixed time interval.
5 . 前記予め定めた時間増分が固定した心拍数低下に相当する時 間間隔である請求の範囲第 3項に記載の心臓治療装置。  5. The heart treatment apparatus according to claim 3, wherein the predetermined time increment is a time interval corresponding to a fixed decrease in heart rate.
6 . 前記予め定めた時間増分が前記計測した心拍間隔の関数であ ることを特徴とする請求の範囲第 3項に記載の心臓治療装置。  6. The heart treatment device according to claim 3, wherein the predetermined time increment is a function of the measured heartbeat interval.
7 . 前記関数が前記計測した心拍間隔の所定の割合である請求の 範囲第 6項に記載の心臓治療装置。 7. The cardiac treatment apparatus according to claim 6, wherein the function is a predetermined ratio of the measured heartbeat interval.
8 . 前記予め定めた期間は限界値を有し、 前記予め定めた期間が 前記限界値を超えるこ とのないよ う に調節される請求の範囲第 1 項に記載の心臓治療装置。 8. The first claim, wherein the predetermined period has a limit value, and the predetermined period is adjusted so as not to exceed the limit value. Item 7. A heart treatment device according to item 1.
9 . 心臓の自己収縮を検出するステップと、  9. Detecting heart self-systole;
前記自 己収縮に関する検出結果から心臓の拍動を計測するス テツプと、  A step of measuring the heart beat from the detection result regarding the self-contraction,
予め定めた期間内に前記心臓の自 己収縮が検出されなかった 場合に心臓を刺激するステップと、  Stimulating the heart if no self-contraction of the heart is detected within a predetermined time period;
前記心臓の拍動を検出 した心拍出力と予め定めた心拍閾値を 比較するステップと、  Comparing a heart rate output that has detected the heart beat with a predetermined heart rate threshold;
前記比較ステ ップの結果に基づいて迷走神経刺激を行う か否 かを決定するステップ、 を有し、  Determining whether to perform vagus nerve stimulation based on the result of the comparison step,
前記決定ステップにおいて迷走神経刺激を行った場合に、 前記 予め定めた期間を前記計測した心拍出力に基づいて変更するステ ップを有するこ と を特徴とする心臓治療方法。  A cardiac treatment method, comprising a step of changing the predetermined period based on the measured heartbeat output when vagus nerve stimulation is performed in the determining step.
1 0 . 前記計測した心拍出力が心拍間隔であるこ とを特徴とする 請求の範囲第 9項に記載の心臓治.療方法。  10. The method for treating or treating a heart according to claim 9, wherein the measured heartbeat output is a heartbeat interval.
1 1 . 前記予め定めた期間を前記計測した心拍出力に基づいて変 更するステップが、 前記計測した心拍間隔に予め定めた時間増分 を加えるものである請求の範囲第 1 0項に記載の心臓治療方法。 11. The heart according to claim 10, wherein the step of changing the predetermined period based on the measured heartbeat output is to add a predetermined time increment to the measured heartbeat interval. Method of treatment.
1 2 . 前記予め定めた時間増分が固定した時間間隔である請求の 範囲第 1 1項に記載の心臓治療方法。 12. The method for treating a heart according to claim 11, wherein the predetermined time increment is a fixed time interval.
1 3 . 前記予め定めた時間增分が固定した心拍数低下に相当する 時間間隔である請求の範囲第 1 1項に記載の心臓治療方法。  13. The heart treatment method according to claim 11, wherein the predetermined time 增 minutes is a time interval corresponding to a fixed decrease in heart rate.
1 4 . 前記予め定めた時間増分が前記計測した心拍間隔の関数で ある請求の範囲第 1 1項に記載の心臓治療方法。  14. The method according to claim 11, wherein the predetermined time increment is a function of the measured heart beat interval.
1 5 . 前記関数が前記計測した心拍間隔の所定の割合である請求 の範囲第 1 4項に記載の心臓治療方法。 15. The method according to claim 14, wherein the function is a predetermined ratio of the measured heartbeat interval.
1 6 . 前記予め定めた期間は限界値を有し、 前記予め定めた期間 が前記限界値を超えるこ との無いよ う に調節される請求の範囲第 項に記載の心臓治療方法, 16. The predetermined period has a limit value, and the predetermined period is adjusted so as not to exceed the limit value. Heart treatment method according to the paragraph,
PCT/JP2004/003618 2003-03-27 2004-03-18 Heart treatment device and heart treating method WO2004084990A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003089358A JP4252833B2 (en) 2003-03-27 2003-03-27 Heart treatment equipment
JP2003/89358 2003-03-27

Publications (1)

Publication Number Publication Date
WO2004084990A1 true WO2004084990A1 (en) 2004-10-07

Family

ID=33095140

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2004/003618 WO2004084990A1 (en) 2003-03-27 2004-03-18 Heart treatment device and heart treating method

Country Status (2)

Country Link
JP (1) JP4252833B2 (en)
WO (1) WO2004084990A1 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7647114B2 (en) 2003-12-24 2010-01-12 Cardiac Pacemakers, Inc. Baroreflex modulation based on monitored cardiovascular parameter
US7706884B2 (en) 2003-12-24 2010-04-27 Cardiac Pacemakers, Inc. Baroreflex stimulation synchronized to circadian rhythm
US7747323B2 (en) 2004-06-08 2010-06-29 Cardiac Pacemakers, Inc. Adaptive baroreflex stimulation therapy for disordered breathing
US7783353B2 (en) 2003-12-24 2010-08-24 Cardiac Pacemakers, Inc. Automatic neural stimulation modulation based on activity and circadian rhythm
US7787946B2 (en) 2003-08-18 2010-08-31 Cardiac Pacemakers, Inc. Patient monitoring, diagnosis, and/or therapy systems and methods
US7869881B2 (en) 2003-12-24 2011-01-11 Cardiac Pacemakers, Inc. Baroreflex stimulator with integrated pressure sensor
US8000793B2 (en) 2003-12-24 2011-08-16 Cardiac Pacemakers, Inc. Automatic baroreflex modulation based on cardiac activity
US8002553B2 (en) 2003-08-18 2011-08-23 Cardiac Pacemakers, Inc. Sleep quality data collection and evaluation
US8024050B2 (en) 2003-12-24 2011-09-20 Cardiac Pacemakers, Inc. Lead for stimulating the baroreceptors in the pulmonary artery
US8121693B2 (en) 2003-12-24 2012-02-21 Cardiac Pacemakers, Inc. Baroreflex stimulation to treat acute myocardial infarction
US8126560B2 (en) 2003-12-24 2012-02-28 Cardiac Pacemakers, Inc. Stimulation lead for stimulating the baroreceptors in the pulmonary artery
US8131362B2 (en) 2005-03-11 2012-03-06 Cardiac Pacemakers, Inc. Combined neural stimulation and cardiac resynchronization therapy
US8170668B2 (en) 2006-07-14 2012-05-01 Cardiac Pacemakers, Inc. Baroreflex sensitivity monitoring and trending for tachyarrhythmia detection and therapy
US8190257B2 (en) 2005-04-05 2012-05-29 Cardiac Pacemakers, Inc. System to treat AV-conducted ventricular tachyarrhythmia
US8200331B2 (en) 2004-11-04 2012-06-12 Cardiac Pacemakers, Inc. System and method for filtering neural stimulation
US8606356B2 (en) 2003-09-18 2013-12-10 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
US8660648B2 (en) 2005-10-24 2014-02-25 Cardiac Pacemakers, Inc. Implantable and rechargeable neural stimulator
US8805494B2 (en) 2005-05-10 2014-08-12 Cardiac Pacemakers, Inc. System and method to deliver therapy in presence of another therapy
US8929990B2 (en) 2005-04-11 2015-01-06 Cardiac Pacemakers, Inc. Transvascular neural stimulation device and method for treating hypertension
US9020595B2 (en) 2003-12-24 2015-04-28 Cardiac Pacemakers, Inc. Baroreflex activation therapy with conditional shut off

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8682429B2 (en) 2010-08-31 2014-03-25 Olympus Corporation Nerve stimulation apparatus
JP5646281B2 (en) 2010-10-28 2014-12-24 オリンパス株式会社 Nerve stimulator

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0838626A (en) * 1994-06-24 1996-02-13 Pacesetter Ab Medical treatment device for superior ventricle of heart
JPH0852121A (en) * 1994-06-24 1996-02-27 Pacesetter Ab Arhythmia detecting device
JPH0919502A (en) * 1995-07-04 1997-01-21 Pacesetter Ab Device and method for detection threshold level adjustment change of sensor
US6473644B1 (en) * 1999-10-13 2002-10-29 Cyberonics, Inc. Method to enhance cardiac capillary growth in heart failure patients

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0838626A (en) * 1994-06-24 1996-02-13 Pacesetter Ab Medical treatment device for superior ventricle of heart
JPH0852121A (en) * 1994-06-24 1996-02-27 Pacesetter Ab Arhythmia detecting device
JPH0919502A (en) * 1995-07-04 1997-01-21 Pacesetter Ab Device and method for detection threshold level adjustment change of sensor
US6473644B1 (en) * 1999-10-13 2002-10-29 Cyberonics, Inc. Method to enhance cardiac capillary growth in heart failure patients

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8002553B2 (en) 2003-08-18 2011-08-23 Cardiac Pacemakers, Inc. Sleep quality data collection and evaluation
US8915741B2 (en) 2003-08-18 2014-12-23 Cardiac Pacemakers, Inc. Sleep quality data collection and evaluation
US7787946B2 (en) 2003-08-18 2010-08-31 Cardiac Pacemakers, Inc. Patient monitoring, diagnosis, and/or therapy systems and methods
US9014819B2 (en) 2003-09-18 2015-04-21 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
US8606356B2 (en) 2003-09-18 2013-12-10 Cardiac Pacemakers, Inc. Autonomic arousal detection system and method
US8874211B2 (en) 2003-12-23 2014-10-28 Cardiac Pacemakers, Inc. Hypertension therapy based on activity and circadian rhythm
US8131373B2 (en) 2003-12-24 2012-03-06 Cardiac Pacemakers, Inc. Baroreflex stimulation synchronized to circadian rhythm
US9440078B2 (en) 2003-12-24 2016-09-13 Cardiac Pacemakers, Inc. Neural stimulation modulation based on monitored cardiovascular parameter
US8024050B2 (en) 2003-12-24 2011-09-20 Cardiac Pacemakers, Inc. Lead for stimulating the baroreceptors in the pulmonary artery
US8121693B2 (en) 2003-12-24 2012-02-21 Cardiac Pacemakers, Inc. Baroreflex stimulation to treat acute myocardial infarction
US8126560B2 (en) 2003-12-24 2012-02-28 Cardiac Pacemakers, Inc. Stimulation lead for stimulating the baroreceptors in the pulmonary artery
US7647114B2 (en) 2003-12-24 2010-01-12 Cardiac Pacemakers, Inc. Baroreflex modulation based on monitored cardiovascular parameter
US11154716B2 (en) 2003-12-24 2021-10-26 Cardiac Pacemakers, Inc. System for providing stimulation pattern to modulate neural activity
US10369367B2 (en) 2003-12-24 2019-08-06 Cardiac Pacemakers, Inc. System for providing stimulation pattern to modulate neural activity
US9950170B2 (en) 2003-12-24 2018-04-24 Cardiac Pacemakers, Inc. System for providing stimulation pattern to modulate neural activity
US9020595B2 (en) 2003-12-24 2015-04-28 Cardiac Pacemakers, Inc. Baroreflex activation therapy with conditional shut off
US8000793B2 (en) 2003-12-24 2011-08-16 Cardiac Pacemakers, Inc. Automatic baroreflex modulation based on cardiac activity
US8285389B2 (en) 2003-12-24 2012-10-09 Cardiac Pacemakers, Inc. Automatic neural stimulation modulation based on motion and physiological activity
US8442640B2 (en) 2003-12-24 2013-05-14 Cardiac Pacemakers, Inc. Neural stimulation modulation based on monitored cardiovascular parameter
US7783353B2 (en) 2003-12-24 2010-08-24 Cardiac Pacemakers, Inc. Automatic neural stimulation modulation based on activity and circadian rhythm
US8457746B2 (en) 2003-12-24 2013-06-04 Cardiac Pacemakers, Inc. Implantable systems and devices for providing cardiac defibrillation and apnea therapy
US8473076B2 (en) 2003-12-24 2013-06-25 Cardiac Pacemakers, Inc. Lead for stimulating the baroreceptors in the pulmonary artery
US7869881B2 (en) 2003-12-24 2011-01-11 Cardiac Pacemakers, Inc. Baroreflex stimulator with integrated pressure sensor
US8626301B2 (en) 2003-12-24 2014-01-07 Cardiac Pacemakers, Inc. Automatic baroreflex modulation based on cardiac activity
US9561373B2 (en) 2003-12-24 2017-02-07 Cardiac Pacemakers, Inc. System to stimulate a neural target and a heart
US7706884B2 (en) 2003-12-24 2010-04-27 Cardiac Pacemakers, Inc. Baroreflex stimulation synchronized to circadian rhythm
US8805513B2 (en) 2003-12-24 2014-08-12 Cardiac Pacemakers, Inc. Neural stimulation modulation based on monitored cardiovascular parameter
US9265948B2 (en) 2003-12-24 2016-02-23 Cardiac Pacemakers, Inc. Automatic neural stimulation modulation based on activity
US8805501B2 (en) 2003-12-24 2014-08-12 Cardiac Pacemakers, Inc. Baroreflex stimulation to treat acute myocardial infarction
US8818513B2 (en) 2003-12-24 2014-08-26 Cardiac Pacemakers, Inc. Baroreflex stimulation synchronized to circadian rhythm
US8442638B2 (en) 2004-06-08 2013-05-14 Cardiac Pacemakers, Inc. Adaptive baroreflex stimulation therapy for disordered breathing
US9872987B2 (en) 2004-06-08 2018-01-23 Cardiac Pacemakers, Inc. Method and system for treating congestive heart failure
US7747323B2 (en) 2004-06-08 2010-06-29 Cardiac Pacemakers, Inc. Adaptive baroreflex stimulation therapy for disordered breathing
US8200332B2 (en) 2004-11-04 2012-06-12 Cardiac Pacemakers, Inc. System and method for filtering neural stimulation
US8768462B2 (en) 2004-11-04 2014-07-01 Cardiac Pacemakers, Inc. System and method for filtering neural stimulation
US8200331B2 (en) 2004-11-04 2012-06-12 Cardiac Pacemakers, Inc. System and method for filtering neural stimulation
US8131362B2 (en) 2005-03-11 2012-03-06 Cardiac Pacemakers, Inc. Combined neural stimulation and cardiac resynchronization therapy
US8909337B2 (en) 2005-04-05 2014-12-09 Cardiac Pacemakers, Inc. System to treat AV-conducted ventricular tachyarrhythmia
US8190257B2 (en) 2005-04-05 2012-05-29 Cardiac Pacemakers, Inc. System to treat AV-conducted ventricular tachyarrhythmia
US8929990B2 (en) 2005-04-11 2015-01-06 Cardiac Pacemakers, Inc. Transvascular neural stimulation device and method for treating hypertension
US8805494B2 (en) 2005-05-10 2014-08-12 Cardiac Pacemakers, Inc. System and method to deliver therapy in presence of another therapy
US9504836B2 (en) 2005-05-10 2016-11-29 Cardiac Pacemakers, Inc. System and method to deliver therapy in presence of another therapy
US8660648B2 (en) 2005-10-24 2014-02-25 Cardiac Pacemakers, Inc. Implantable and rechargeable neural stimulator
US8170668B2 (en) 2006-07-14 2012-05-01 Cardiac Pacemakers, Inc. Baroreflex sensitivity monitoring and trending for tachyarrhythmia detection and therapy

Also Published As

Publication number Publication date
JP4252833B2 (en) 2009-04-08
JP2004290536A (en) 2004-10-21

Similar Documents

Publication Publication Date Title
JP4252833B2 (en) Heart treatment equipment
JP4252830B2 (en) Heart treatment equipment
US7305265B2 (en) Heart treatment equipment for treating heart failure
JP4173643B2 (en) A system that provides ventricular pacing and bi-chamber coordination
US8792979B2 (en) Method and apparatus for preventing cardiac arrhythmias with endovascular stimulation
JP4439215B2 (en) Heart treatment equipment
EP1888167B1 (en) Device for comprehensive anti-tachyarrhythmia therapy
JP4852707B2 (en) Medical device and method for identifying arrhythmia events
JP4262596B2 (en) Method and apparatus for controlling the delivery of high voltage and anti-tachycardia pacing therapy in an implantable medical device
US8046061B2 (en) System and method for preventing recurrence of atrial tachyarrhythmia
JP4937903B2 (en) Method and apparatus for controlling delivery of high voltage and anti-tachycardia pacing therapy in an implantable medical device
JP2007507316A (en) Cardiac pacing modality with improved blanking, timing, and therapy delivery methods for extra systolic stimulation pacing therapy
JPH0838626A (en) Medical treatment device for superior ventricle of heart
JPH06508270A (en) Method and device for identifying stable and unstable ventricular tachycardia
JP2004173790A (en) Heart treatment equipment
JP4252826B2 (en) Heart treatment equipment
JP4594735B2 (en) Pacing treatment to prolong the atrial refractory period
JP4381044B2 (en) Heart treatment equipment
JP4177086B2 (en) Heart treatment equipment
JP2004180988A (en) Heart treatment equipment
JP4624159B2 (en) Heart treatment equipment
JP2006263349A (en) Heart treating instrument
JP4575210B2 (en) Heart treatment equipment
JP2004350859A (en) Cardiotherapy equipment
JP4563785B2 (en) Heart treatment equipment

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase